Sei sulla pagina 1di 79

1 14 - NATURAL HISTORY OF UNDESCENDED TESTES Formatted: Numbering: Continuous

12 8 a. Caudal regression syndrome
13 8 b. Prune-belly syndrome or Eagle-Barrett syndrome
14 8 c. CHARGE syndrome
18 10 a. Testicular cancer
19 10 b. Infertility

23 Cryptorchidism is one of the most frequent problems encountered in pediatric

24 urology. Its etiology, associated lesions and prognosis in terms of fertility have
25 been a source of interest and discrepancies for pediatric pathologists and
26 urological surgeons.

28 Keywords: Cryptorchidism, Retractile testes, Testicular dysgenesis, Mixed

29 Atrophy of Testes (MAT).

32 Failure in testicular descent is among the most frequent congenital
33 disorders in newborns. Testicular descent is not always complete at birth.
34 Between four and five percent of newborns have incompletely-descended testes.
35 This percentage is higher in premature newborns, reaching 100% in those
36 weighing less than 900 g at birth (1, 2). Testes usually descend in the first three
37 months of postnatal life, and by the age of one only 0.96 to 1.58% of testes
38 remain undescended. After the first year of life, spontaneous descent is
39 exceptional. The incidence of cryptorchidism seems to have risen in recent
40 years, with the last reported figures around 1.8% of all boys (3, 4).
41 The first item to address when an infant presents with an empty scrotum is
42 whether or not a testis exists, and if it does, where it is located. About five
43 percent of patients presenting with no palpable testis indeed have no testis. The
44 remaining cases can be classified in one of the following categories: true
45 cryptorchidism, testicular ectopia, and retractile testes (5).
46 “True cryptorchidism” defines testes that cannot be moved into the
47 scrotum during physical exploration. They may be located in the abdomen,
48 inguinal duct, or high in the scrotum (6).
49 Ectopic testes are located outside the normal pathway of testicular
50 descent. This group includes the classic ectopies: interstitial (superficial
51 inguinal), femoral (crural), perineal, transverse (crossed testicular ectopia), pubo-
52 penile, pelvic, and other more rare ectopies such as testes in the abdominal wall.
53 (See Chapter 9 Alterations in Number and Location)
54 Retractile testes represent between one-fourth and one-third of testes
55 clinically diagnosed as undescended testes. Retractile testes can be mobilized to
56 the bottom of the scrotum with adequate gentle manipulation.
57 True cryptorchidism represents about 25% of the patients consulting for an
58 empty scrotum. Canalicular (inguinal canal) and high scrotal cryptorchid testes
59 are more common than those with intra-abdominal locations. The latter are found
60 in only five to ten percent of cases. The right side is slightly more frequently
61 involved than the left. In about 18% of cases, cryptorchidism is bilateral.
62 Approximately 14% of cryptorchid patients have a family history of cryptorchidism
63 (7, 8).

64 From an epidemiological viewpoint, the risk of cryptorchidism increases in

65 seemingly disparate situations. These include increased maternal age, maternal
66 obesity, toxemia of pregnancy, alcohol consumption, late pregnancy bleeding,
67 exposure to endocrine-disrupting chemicals during fetal development (9, 10),
68 smoking during pregnancy, high maternal stature, history of subfertility, birth by
69 cesarean section, low weight at birth, prematurity, twinning, intrauterine growth
70 restriction (11), hypospadias (12), other congenital malformations, and births
71 occurring between September and November or during May and June (13, 14).
72 The highest risk is associated with low weight at birth (15). In children, the most
73 common methods for the diagnosis of cryptorchidism are physical examination
74 and surgical evaluation. The value of ultrasonography is controversial (16, 17).


77 The causes of testicular maldescent are probably multiple and have not
78 been completely elucidated (see Chapter 2 Factors Involved in Testicular
79 Descent). There are two types of cryptorchidism: congenital and acquired.
80 Congenital cryptorchidism may be due to hormonal dysfunction involving
81 testosterone, anti-müllerian hormone (AMH), epidermal growth factor (EGF) and
82 estrogens. Mechanical causes include anatomical anomalies of the
83 gubernaculum, insufficient abdominal pressure, short spermatic cord,
84 underdeveloped vaginal process, and maldeveloped epididymis. Neuromuscular
85 causes include abnormalities in the calcitonin gene-related peptide (CGRP) and
86 the cremaster nucleus. Genetic causes are mutations in the insulin-like factor 3
87 or its receptor (18). Other hereditary (19, 20) or acquired conditions may produce
88 cryptorchidism.
89 In most cases, cryptorchidism is due to a deficit of fetal androgens or an
90 excess of maternal estrogens. Fetal androgen deficit seems to occur during the
91 second and third trimesters of gestation and is caused by either deficient pituitary
92 gonadotropic stimulation or low placental gonadotropins. Androgen insufficiency
93 seems to be slight and transient, because genital anomalies other than abnormal
94 epididymis growth (21) have been observed. In addition, no alterations on the
95 androgen-regulating gene have been found (22). Elevated levels of maternal
96 estrogens might induce feedback inhibition of follicle stimulating hormone (FSH)
97 by the fetal pituitary. This results in low Sertoli cell proliferation (23), and possibly
98 decreased testosterone production due to inhibitory effects of estrogens on
99 Leydig cells (24).
100 Unilateral cryptorchidism would be explained on the basis of androgenic
101 failure, causing either an ipsilateral anomaly in the development of genito-femoral
102 nerve neurons, or a defect in calcitonin gene-related peptide (CGRP) release
103 which would interfere with the normal migration of the gubernaculum (25).
104 The term “acquired cryptorchidism” refers to descended scrotal testes that,
105 during postnatal life, can ascend and be lodged even in the abdominal cavity (26).
106 This is seen in 1.5% of prepubertal boys (27). Two types of acquired
107 undescended testes have been considered: a) the so-called postoperative
108 “trapped testis” (28) is a normally-descended testis that “escapes” from the
109 scrotum after surgery for inguinal hernia or hydrocele (29-31). This iatrogenic
110 complication may occur in 1.2% of children who undergo hernia repair. An
111 adherence of the testis or the cremaster muscle to the surgically-incised zone
112 causes upward displacement of the testis by myofibroblastic contraction during
113 wound healing. b) The spontaneously-ascended testis. This is considered a late
114 manifestation of congenital cryptorchidism, and has been explained by the “yo-
115 yo” model (32).
116 At birth, a 4-5 cm long spermatic cord allows the testis to become scrotal
117 (descended). As the boy grows, if the spermatic cord does not elongate up to 8-
118 10 cm, the testis ascends again, attaining a high or completely inguinal location
119 around three to six years of age. At puberty, the testosterone effect will cause
120 elongation of the spermatic cord and spontaneous descent of the testis in 77.5%
121 of the cases (33).
122 The etiology of spontaneously-ascended testis is not known but several
123 hypotheses have been proposed. Failure in postnatal spermatic cord elongation
124 is one cause (34-36). This elongation cannot take place if the peritoneo-vaginal
125 duct has become a fibrous remnant (37). Another defect is in the postnatal
126 release of CGRP by the genito-femoral nerve (38). Still other causes include
127 inadequate growth of spermatic vessels (39), failure in reabsorption of the vaginal
128 process (40), permanent spasm of the cremaster muscle (41), abnormal insertion
129 of the gubernaculum (42), and deficient or decreased androgen activity (43).


133 No functional studies exist to assess the presence and severity of
134 congenital lesions in cryptorchid testes. Histological study is necessary to
135 evaluate damage of the testicular parenchyma in cryptorchidism. We must keep
136 in mind that the testis is a dynamic structure with waves of proliferation and
137 differentiation from birth to puberty (see Chapter 3). Testicular volume increases
138 40-fold by the end of puberty. Measuring approximately 0.5 ml at birth, the testis
139 grows slowly to about 0.6 ml by three years of age and about 1-2 ml in
140 prepubertal boys. Growth then accelerates, reaching 20 ml at puberty.
141 Undescended testes have slower growth and reduced volume, noticeable from
142 six months of age (44) (Fig 1).
143 The parameters usually applied to study adult testicular parenchyma
144 should not be used for prepubertal testes (45). In order to maximize the value of
145 histological assessment of undescended testes, we need to apply both
146 semiquantitative and qualitative parameters. Semiquantitative morphometric
147 parameters include: mean tubular diameter (MTD); tubular fertility index (TFI);
148 number of germ cells per cross-sectioned tubule; Sertoli cell index (SCI); and
149 number of interstitial cells of Leydig. Qualitative findings include: the pattern
150 (regular or irregular) of germ cell distribution within testicular parenchyma;
151 presence of abnormal spermatogonia (multinucleated, hypertrophic and/or
152 atypical) and gonocytes; focal granular changes in Sertoli cells; abnormal tubules
153 (megatubules, ring-shaped tubules); microliths; and androgen receptors in
154 children older than four years of age.
155 Most cryptorchid testes develop lesions in the first year of life, supporting
156 the notion of a primary origin rather than being acquired due to long-standing
157 cryptorchidism. These patients fail to undergo the so-called “minipuberty” which
158 is characterized by increased pituitary gonadotropins and a testosterone peak
159 between three and six months of age (46). This lack of hormonal stimulation has
160 four important consequences: 1) an incomplete migration of gonocytes and fetal
161 spermatogonia from the center of the seminiferous tubules to the periphery
162 where they are to lay over the basal membrane; 2) defective transformation of
163 gonocytes into A dark spermatogonia (Ad); 3) persistence of gonocytes after the
164 first year of life; and, 4) failure of primary spermatocytes to appear by three to
165 four years of age (47).
166 The most frequent histological findings during infancy, in both congenital
167 and acquired cryptorchidism, are decreased germ cell number and reduction in
168 tubular diameter (48). Based on four parameters (TFI, MTD, SCI and the
169 spermatogonial distribution pattern), most testicular biopsies from cryptorchid
170 testes in children less than four years of age can be classified in three types.
171 Type I: testes with slight alterations (31% of undescended testes) (Fig 2).
172 Type II: testes with marked germinal hypoplasia (29%) (Fig 3).
173 Type III: testes with severe germinal hypoplasia (40%) (49) (Figs 4 and 5)
174 (Table 1).
175 About eight percent of testes with type I lesions show many multinucleated
176 spermatogonia (with three or more nuclei) (50) (Figs 6 and 7) and persistent
177 expression of CD117 (c-Kit) and placental alkaline phosphatase (PLAP) in about
178 five percent of immature germ cells. Seminiferous tubules of testes with type II or
179 III lesions show thickened lamina propria during childhood and Sertoli cell
180 hyperplasia at puberty. More than 30% of these testes have microliths (Fig 8),
181 ring-shaped tubules (Fig 9), and granular change in Sertoli cells (Figs 10 and 11).
182 Type I lesions are comparable to those in experimental cryptorchidism, and also
183 in normal testes with lesions induced by increased temperature (51).
184 Patients with bilateral cryptorchidism have a higher incidence of type II
185 and III lesions compared to those with unilateral cryptorchidism. Bilateral
186 cryptorchid testes feature variable abnormalities that, in addition to germ cells,
187 involve Sertoli cells, peritubular myofibroblasts, and Leydig cells. These lesions
188 become evident only after puberty (52), and are more severe in intra-abdominal
189 testes (53).
190 In unilateral cryptorchidism, the contralateral scrotal testis also displays
191 histologic lesions of variable severity, with an incidence ranging from 23 to 60%.
192 These lesions are usually less severe in the scrotal than in the contralateral
193 cryptorchid testis, but may also be similar or even more severe. These findings
194 support the hypothesis of a bilateral defect in many cases of unilateral
195 cryptorchidism.
196 Microdeletions in the long arm of the Y chromosome, including the DAZ,
197 RBM, and AZF a, b, and c genes, are not increased in cryptorchidism (54).
198 In cryptorchid testes that undergo spontaneous ascent, lesions develop
199 later and are similar to those found in congenital cryptorchidism (55). Patients
200 with cryptorchidism following herniotomy show less decrease of germ cell
201 number (56). This is only evident after the age of five years (57).


204 During puberty, undescended testes have a severe maturation delay in
205 both tubular and interstitial components (58). Seminiferous tubules display an
206 apparent Sertoli cell hyperplasia per cross-sectioned tubule. This results from a
207 failure in lengthening and coiling of seminiferous tubules during pubertal
208 development (Fig 12). They also show decreased diameters, and when germ
209 cells are present, they have delayed proliferation. Frequently, as puberty
210 progresses, testicular development is irregular, varying from one testicular lobule
211 to another (Fig 13). Seminiferous tubules that have initiated spermatogenesis are
212 adjacent to others showing a prepubertal maturation pattern. Careful study
213 reveals delay in Sertoli cell maturation as estimated by nuclear morphology.
214 Irregular expression of androgen receptors in these Sertoli cells has been
215 detected by immunohistochemical methods (59) (Fig 14). Tubules with
216 prepubertal pattern also show delayed maturation of myofibroblasts which are
217 unable to express muscle specific actin (Fig 15). The interstitium appears
218 progressively more fibrotic (Figs 16 and 17).


221 Histological analyses of most cryptorchid testes from adults reveal lesions
222 in all their structural components, including rete testis and epididymis.
223 Seminiferous tubules have reduced diameters and deficient spermatogenesis.
224 The most frequent germ cell pattern is spermatogonial maturation arrest (Fig 18).
225 This is followed by Sertoli-cell-only tubules with dysgenetic Sertoli cells (Fig 19),
226 mixed atrophy (Fig 20) and diffuse tubular sclerosis (Fig 21).
227 Nuclei of Sertoli cells are normal only in tubules with advanced
228 spermatogenesis (60). Dysgenetic Sertoli cells within Sertoli-cell-only tubules
229 show positive immunostaining for vimentin (similar to normal adult Sertoli cells).
230 They may also express cytokeratins and desmin in the basal cytoplasm. This
231 staining pattern is also seen in intraluminal aggregates of sloughed Sertoli cells
232 (61).

233 The tubular wall has decreased elastic fibers (62) (Fig 22). Increased
234 collagenization, irregular deposits of collagen IV (Fig 23) and laminin are found
235 in the basal lamina (52). In experimental cryptorchidism, peritubular myoid cells
236 have disorganized actin filaments (63).
237 Undescended testes removed from adults often present straight or slightly
238 coiled tubules with frequent branching (Fig 24). These testes also have
239 hypoplastic tubules with a small lumen and thick wall, lined by a tall columnar
240 epithelium formed only by Sertoli cells of eosinophilic cytoplasm (Fig 25). Other
241 abnormalities in cryptorchid adult testes include Sertoli cells nodules (Fig 26)
242 (see Chapter 11), seminiferous tubules with granular changes in Sertoli cells (Fig
243 27), and Leydig cell hyperplasia (Fig 28). Interstitial Leydig cells often contain
244 cytoplasmic vacuoles; their number is truly increased in some cases, and only
245 apparently increased in others. Testicular parenchyma adjacent to the rete testis
246 often has foci of adipose metaplasia.
247 Most cryptorchid testes, especially those with Sertoli-cell-only tubules,
248 show an underdeveloped rete testis. The epithelium has not differentiated into
249 squamous and columnar cells (as is normal in puberty). The epithelium retains
250 an infantile pattern (64). This has been called “dysgenetic rete testis”. Other rete
251 testis anomalies are frequent, including hypoplasia, cystic hypoplasia and
252 adenomatous hyperplasia (65) (Fig 29).
253 Biopsies and fine-needle aspiration studies of the normally-descended
254 contralateral testis (66) show a variety of histological patterns from normal to
255 alterations similar to those of cryptorchid testes (Figs 30 and 31). This variability
256 is probably related to the cause of cryptorchidism. Bilateral lesions suggest a
257 congenital or genetic cause, whereas normal contralateral testes suggest local
258 anatomical abnormalities (67).


262 In institutions with a large number of pediatric and adult testicular biopsies,
263 it is possible to compare histologic findings in bilateral testicular biopsies taken at
264 orchidopexy from cryptorchid children, with those obtained from the same
265 patients at adulthood performed for evaluation of infertility. In a series of 21 such
266 patients (68), more than two-thirds of testes with higher tubular fertility index
267 (normal testes and those with type I lesions) revealed diffuse and complete
268 spermatogenesis, although they showed quantitatively abnormal germ cell
269 numbers (Fig 32). The remaining cases developed mixed atrophy of the testis
270 (MAT) (69). MAT is defined as the synchronous occurrence of tubules containing
271 germ cells (with variable degrees of spermatogenesis) and Sertoli-cell-only
272 tubules (Fig 33). All testes with type II lesions and 85% of those with type III
273 lesions developed MAT, leading us to conclude that MAT is the most frequent
274 lesion (68.29%) in adult excryptorchid patients presenting with infertility (Table 2).
275 In most patients with unilateral cryptorchidism, MAT was observed in both
276 undescended testis and contralateral descended testis, even if the surgical
277 correction occurred at an early age. An inverse correlation was found between
278 the severity of the testicular lesions in childhood and the amount of
279 spermatogenesis in adulthood. About 85% of adult testes with type III lesions in
280 infancy developed MAT with spermatogenesis in less than 50% of tubules.
281 Another five percent of these testes showed hypospermatogenesis plus
282 spermatocyte I sloughing (Fig 34); around ten percent presented Sertoli-cell-only
283 tubules throughout the testis (Fig 35). Prepubertal testes with clustering of germ
284 cell-containing tubules usually have incomplete spermatogenesis in adulthood
285 and, if this was complete, it occurred in less than 50% of tubules (68).
286 Anomalies of the sperm excretory ducts occur in 9 to 36% of cryptorchid
287 patients (70, 71) (Fig 36). Since these anomalies can cause obstruction of the
288 excretory ducts, testicular biopsies can also reveal an obstructive pattern
289 superimposed on the seminiferous tubule lesions (Fig 32).
290 In summary, the classification of childhood testicular lesions into types I, II
291 and III correlates with the amount of spermatogenesis in post-pubertal biopsies.
292 The most important parameter is TFI. Spermatogenesis can also be impaired by
293 a complete or incomplete, functional or organic, obstructive process. Testicular
294 biopsy not only allows an adequate evaluation of congenital or obstructive
295 lesions, but also identifies testes with focal spermatogenesis. This opens the
296 possibility of assisted reproduction.


299 Identifying the best treatment for congenital undescended testes has been
300 a matter of debate for decades. The consensus is that surgical treatment is
301 mandatory in cryptorchid infants. In patients with palpable inguinal cryptorchid
302 testes, orchidopexy should be performed within the first year of life, and no later
303 than 18 months of age. This recommendation, issued by the European
304 Association of Urology (72), is supported by several studies (73-76). The Nordic
305 Consensus recommends anticipating orchidopexy as early as the first 6-12
306 months of life (77). Surgical treatment benefits all cases of primary cryptorchidism
307 and also retractile testis, even in children whose testes were surgically
308 descended at a more advanced age (78).
309 The efficacy of hormonal treatments following orchidopexy is still
310 controversial. Results are contradictory and great variations have been reported.
311 While human chorionic gonadotropin (hCG) and gonadotropin-releasing hormone
312 (GnRH) treatments have been effective in some cases of cryptorchidism (77, 79),
313 they have been useless in others (46, 80). A recent meta-analysis has shown that
314 about 15 to 20% of cryptorchid testes descend during hormonal treatment,
315 although one-fifth of these re-ascend later. Furthermore, treatment with hCG
316 increases germ cell apoptosis, with subsequent damage to future
317 spermatogenesis (77). Histology seems to be the safer guide to clarify this
318 controversy. Biopsy is the only method to identify cryptorchid boys who need
319 treatment with luteinizing hormone-releasing hormone (LH-RH) following
320 successful surgery. Consequently, some authors propose that biopsy should be
321 performed routinely during orchidopexy (81). Neonatal gonocytes transform into
322 type A spermatogonia at 3–12 months. This process is disrupted in
323 undescended testes, but orchidopexy at an early age may prevent this disruption.
324 The presence of Ad spermatogonia at the time of surgery is an excellent
325 prognostic indicator of future fertility. Cryptorchid boys lacking these cells will be
326 infertile despite successful orchidopexy at an early age (46). In all testes with low
327 numbers of Ad spermatogonia and suboptimal response to hCG stimulation,
328 hormonal treatments should be advised in an attempt to increase the number of
329 germ cells. The question of whether different modalities and periods of hormonal
330 therapy in patients with impaired Leydig cell response could lead to improved
331 testicular histology (and better fertility) remains to be answered (82, 83).
332 In childhood, the probability of detecting an occult cancer or a
333 precancerous lesion in a biopsy is low because intratubular germ cell neoplasia
334 is not diffusely distributed through the testis, and because of the frequent
335 persistence of gonocytes beyond the first year. However, a testicular biopsy
336 should be performed in all patients with intra-abdominal testes, abnormal
337 external genitalia, or abnormal karyotype (84).
338 Testicular autotransplantation (85) has been used in some patients with
339 high intra-abdominal testes as an alternative to the Fowler-Stephens technique
340 (86, 87). The latter involves transecting the vessels to the testis while bringing it

341 down to the scrotum with the hope that collateral vessels provide adequate
342 circulation. Autotransplanted testes represent approximately five percent of all
343 undescended testes (88). Histological studies performed after autotransplantation
344 have shown Leydig cell development, tubular diameter increase, and some
345 spermatogenesis (89, 90), although no paternity has yet been reported.
346 No consensus has been reached on the treatment of acquired
347 undescended testis. Recommendations vary from surgery at diagnosis to a
348 conservative approach, delaying orchidopexy until puberty. Early surgery
349 prevents injury from elevated temperature, while the conservative stance relies
350 on the effect of testosterone leading to spontaneous descent at puberty (three of
351 four cases) (91). An orchidopexy performed at puberty does not guarantee that
352 the excryptorchid testis will reach a normal volume (92).


355 Most cryptorchid patients (62-90%) have an ipsilateral patent vaginal
356 process (93, 94). This probably enabled the few descents achieved after hormonal
357 treatment (95). Some 34% of patients with unilateral palpable undescended testis
358 have a contralateral patent processus vaginalis (96). Between 65 and 75% of
359 cryptorchid males have a hernia sac, although most are not apparent.
360 Urological anomalies are present in 10.5% of patients. The most frequent
361 are hypospadias (5.7 to 9.3%) (4), complete duplication of the urinary tract, non-
362 obstructive urethral dilation, kidney malrotation, and posterior urethral valves.
363 Cryptorchidism is frequent in patients with nervous system anomalies,
364 including microcephaly, myelomeningocele, and spina bifida (25%) (97). It is also
365 frequent with other malformations such as omphalocele (33%), gastroschisis (30
366 to 38.7%) (98, 99), micropenis, imperforate anus (100, 101), and cloacal exstrophy
367 (102).

368 The incidence of anomalies of the sperm excretory duct is high in patients
369 with undescended testes. They involve both intra- and extratesticular ducts.
370 Dysgenesis of the rete testis is observed in more than 80% of adults with
371 undescended testes (103). The incidence of extratesticular spermatic duct
372 anomalies varies from 36 (104) to 79% (6, 70, 105-108) (see Chapter 12 Congenital
373 Epididymal Anomalies).
374 In addition to macroscopic anomalies, the epididymis features abnormal
375 development of the ductuli efferentes and ductus epididymis from infancy
376 onward. The epithelium of both types of ducts is low and the muscular wall is
377 poorly developed. In cryptorchid adults, cross-sections of the ductuli efferentes
378 have an inner circular outline instead of the wavy outline imparted by the different
379 epithelial heights of the normal epididymis (109). The poor development of muscle
380 in the wall suggests that propulsion of testicular fluid is compromised, resulting in
381 stasis within ductuli efferentes, rete testis, and even seminiferous tubules.
382 A close relationship exists between patent vaginal processes and
383 epididymal anomalies, regardless of the location of the cryptorchid testis. In
384 cryptorchid patients with an open vaginal process, the incidence of these
385 anomalies rises to 80%, whereas it is only 5% in descended testes with closed
386 vaginal processes (110).
387 Anomalies of the gubernaculum are also frequent in cryptorchidism. The
388 gubernaculum is attached to the testis and epididymis in 72.2% of cryptorchid
389 testes, but in 98.8% of normal fetuses. The gubernaculum is attached only to the
390 testis (the cauda epididymis is free) in 22.2% of cryptorchid testes and 1.19% of
391 normal fetal testes. The gubernaculum is attached only to the cauda epididymis
392 in 5.6% of cryptorchid testes, whereas this condition is not observed in normal
393 fetuses (111).
394 Another anomaly is the presence of short spermatic vessels that hinder
395 testicular descent. This is frequent in cryptorchid testes with type III lesions and
396 less frequent in those with type II lesions. This observation further supports the
397 dysgenetic nature of these testes (112).
398 Ultrasonography can produce images that explain many of the anomalies
399 and the poor outcomes after surgical descent of these testes (113).


403 Although cryptorchidism usually appears as an isolated anomaly, it is often
404 associated with congenital endocrine or chromosomal disorders, and disorders of
405 sexual development (114, 115). Cryptorchidism has been reported in patients with
406 GnRH deficit and Maestre de San Juan syndrome (commonly referred to as
407 Kallman syndrome). Cryptorchidism is also found in Prader-Willi, Klinefelter, and
408 Noonan syndromes. Still other conditions with cryptorchidism include testicular
409 feminization caused by androgen-receptor anomalies, 5-α-reductase deficiency,
410 and several types of undermasculinization caused by absent anti-müllerian
411 hormone. The association of impalpable testes with hypospadias suggests a
412 disorder of sexual development. This is confirmed in 27 to 30% of cases (116, 117).
413 Cryptorchidism also occurs in patients with the following syndromes: caudal
414 regression, prune-belly, Smith-Lemli-Opitz, Cornelia De Lange, DiGeorge,
415 Beckwith-Wiedemann (118), Aarkog-Scott (also called Rubinstein-Taybi syndrome
416 or CHARGE association), and trisomies 13, 18, and 21.

418 9 a. Caudal regression syndrome

419 Cryptorchidism has a high incidence in caudal regression syndrome (also
420 called caudal dysplasia syndrome) (119). Cryptorchidism appears in all patients
421 with tritonmelia, the male variant of sirenomelia, and is associated with
422 malformations and dysplasias of the kidney, ureter and spine (T10-S5 levels).
423 This association has been observed in 18% of cryptorchid boys younger than
424 three years of age, 34% of cryptorchid fetuses who died in the third trimester of
425 gestation, and 65% of cryptorchid patients with imperforate anus (120).

427 9 b. Prune-belly syndrome (PBS) or Eagle-Barrett syndrome

428 This syndrome involves musculoskeletal, gastrointestinal, respiratory,
429 cardiovascular, central nervous and genitourinary systems (121, 122). The classic
430 triad described by Osler is comprised of bilateral cryptorchidism, defective or
431 absent abdominal wall musculature (prune belly), and malformation of the
432 urogenital tract. The incidence of this syndrome is 3.8 in 100,000 live male births
433 (123) affecting males almost exclusively (>95%). PBS is lethal in 50% of the

434 affected individuals and is associated with high morbidity in the survivors.
435 The cause of PBS is still unknown although one genomic HNF1 β mutation
436 has been observed in three percent of patients (124) . It can be associated with
437 Turner and Down syndromes, trisomies 18 and 13, monosomy 16, VACTERL
438 association, or Beckwith-Wiedemann syndrome (125-127). PBS has a primary
439 defect of the embryonal lateral and intermediate mesoderm (128). Patients with a
440 prune belly abdomen, but no urinary tract anomalies or cryptorchidism, are
441 known as having “prune belly phenotype” or “pseudo prune belly syndrome” (129,
442 130). This is similar to the megacystic-megaureter syndrome in regard to the

443 flaccid, stretched abdominal wall (131) (Fig 37). Prenatal diagnosis is possible
444 even at the thirteenth week of gestation. The diagnosis of PBS is based on
445 abnormal distension of the urinary bladder and abdomen, and absence of the
446 "keyhole sign" (132).
447 Testes of prune belly patients are intra-abdominal, located at the level of
448 the iliac vessels. When the muscle thinning is not as severe, testes can be
449 located in a lower abdominal position, even in the inguinal canal (133). The
450 testicular lesions may be detected even in fetal life (134). The most remarkable
451 microscopic lesions are germ cell depletion and Leydig cell hyperplasia. Early in
452 infancy, gonocytes (which can be easily detected by their staining with placental
453 alkaline phosphatase) can be present until seven months of age. This suggests
454 an arrest in the normal evolution of these cells, which should have been
455 transformed into spermatogonia in the first months of life. Whether gonocytes
456 degenerate or may be the origin of an infiltrating tumor later is not known (135).
457 Adult patients are azoospermic, their prostate is hypoplastic, and the
458 prostatic urethra is widened. The most frequent histological testicular pattern is
459 Sertoli-cell-only tubules. Leydig cells are normal or hyperplastic. FSH and LH
460 serum levels are elevated, while testosterone levels are normal. Seminomatous
461 and non-seminomatous germ cell tumors have been reported (136, 137).

463 9 c. CHARGE
464 The first descriptions of this syndrome or association appeared
465 independently in the studies of Hall and Hittner, et al in 1979 (138, 139). The
466 acronym CHARGE was coined by Pagon et al in 1981 (140), grouping the most
467 characteristic anomalies: coloboma, congenital heart disease, choanal atresia,
468 retarded growth, mental retardation and/or central nervous system anomalies,
469 genital hypoplasia, ear anomalies and/or deafness. Most cases are sporadic; in
470 familial cases autosomal dominant inheritance has been suggested. The disorder
471 is caused by mutations in CHD7 gene (chromodomain helicase DNA binding
472 protein) in approximately 60 to 70% (141-144) of cases. CDH7 belongs to a protein
473 family involved in chromatin organization in a large number of developmental
474 pathways in fetal life (145). CHARGE incidence is 1 in 10,000 newborns, without
475 gender distinction. This association has several overlapping clinical
476 characteristics with Kallmann syndrome (146), DiGeorge syndrome (147),
477 sensorineural deafness, renal disease (Barakat´s syndrome) and
478 hypoparathyroidism with or without bilateral multicystic renal dysplasia (148).
479 Urinary tract anomalies are present in 10-40% of patients with CHARGE
480 syndrome including renal ectopia, renal agenesis, duplex kidney, horseshoe
481 kidney, urethral anomalies, micropenis, and cryptorchidism. Micropenis and
482 cryptorchidism are expressions of hypogonadotropic hypogonadism which is
483 present even during fetal life (146, 149, 150).


486 The most frequent complications of cryptorchidism are testicular cancer,
487 infertility, testicular torsion, iatrogenic atrophy, and psychological problems
488 derived from an empty scrotum (151).

490 10 a. Testicular cancer

491 Both congenital undescended and contralateral scrotal testes show a
492 higher predisposition to develop testicular cancer compared with testes of the
493 general population. The cancer risk of undescended testis is 6.33 times higher
494 than the general population. For the contralateral testis the risk is 1.74 to 2.90
495 times higher in meta-analysis studies by Akre et al (152) and by Lip et al (153). In
496 Northern countries, the risk of testicular cancer arising in cryptorchid patients is
497 an estimated four times higher than that of the general population (154, 155); with
498 abdominal testes, the risk is six times higher than that of cryptorchid testes with a
499 lower location (154-156). The risk of cancer increases if cryptorchidism is bilateral
500 and associated with anomalies of the external genitalia or with chromosomal
501 anomalies, such as 45, X/46, XY (157).
502 Approximately two to three percent of adult cryptorchid testes show
503 intratubular germ cell neoplasia unclassified/carcinoma in situ (ITGCNU/CIS) (158,
504 159). Half of cryptorchid patients with CIS develop testicular cancer within five

505 years and 70% within seven years. In Denmark, one of the countries with the
506 highest incidence of testicular cancer, an estimated 0.5% of males will develop
507 CIS (160), and one out of five testicular cancers will develop in the contralateral
508 scrotal testis.
509 In infancy, ITGCNU/CIS may go undetected. Atypical gonocytes may not
510 be located directly over the tubular basement membrane but in the center of the
511 lumen, and their numbers may be very low (161). In five percent of testicular
512 biopsies in infants, cells similar to those of ITGCNU/CIS have been observed,
513 although progression toward an infiltrating tumor is not agreed upon (162, 163).
514 Cryptorchid testes with numerous multinucleated spermatogonia seem to be
515 associated with increased risk of testicular malignancy later in life (50).
516 The most frequent tumor in cryptorchid testes is seminoma (164).
517 Orchidopexy, independent of age, does not decrease the risk of cancer but
518 allows for earlier detection (165). The prognosis of germ cell tumors in intra-
519 abdominal testes is similar to that of tumors in normally-descended testes (166),
520 although the disease may be more advanced at the time of diagnosis.
521 The incidence of tumors in patients with acquired cryptorchidism should
522 not be different from that of the normal population. In these patients the testicular
523 ascent is a late event, months or years after gonocytes had transformed into
524 spermatogonia during a normal minipuberty (167).

526 10 b. Infertility
527 Infertility is one of the most frequent problems of cryptorchid men. From
528 2.5% (168) to 9% (169) of infertile men are or were affected by cryptorchidism.
529 Cryptorchidism-related infertility depends on several factors; bilateral or
530 unilateral cryptorchidism, location and size of the cryptorchid testis, tubular
531 fertility index, number of germ cells per cross-section, germ cell distribution,
532 anomalous DNA content in germ cells, congenital anomalies of sperm excretory
533 ducts, and iatrogenic injury to the testes, epididymis, ductus deferens or
534 spermatic cord during orchidopexy (170).
535 Bilaterality of the lesion. Only 16 (171) to 25% (172) of bilateral cryptorchid
536 patients have sperm concentrations above 20 million/ml. Patients with bilateral
537 impalpable testes (172, 173) or with associated elevation of FSH levels (104) have
538 azoospermia or severe oligozoospermia. In contrast, 31 to 55.8% of men with
539 unilateral cryptorchidism have sperm concentrations over 20 million/ml, 38.2 to
540 62% have oligozoospermia, and only 6 to 7.6% show azoospermia (174, 175).
541 Paternity rates are 50 to 63.3% in bilateral cryptorchidism, 89.7% in unilateral
542 cryptorchidism and 93.2% in controls (176). The time elapsed from orchidopexy to
543 fertilization is longer in patients who suffered bilateral cryptorchidism (177). Many
544 patients with repaired bilateral cryptorchidism require assisted fertilization
545 techniques such as intracytoplasmic sperm injection (ICSI), to achieve successful
546 fertilization (178).
547 Both location and size of the cryptorchid testis have been considered
548 important. It is assumed that patients with high scrotal testes, or testes lodged in
549 the superficial inguinal pouch, show the best spermiograms, and that patients
550 with intra-abdominal or canalicular testes are oligozoospermic or azoospermic.
551 The more severe testicular malfunctions can be due to either more severe
552 histological lesions (53), or injury produced during orchidopexy, because these
553 testes require more mobilization than those in lower locations (179). Patients
554 whose testes are nearly normal in size also have better spermiograms (172).
555 Nevertheless, some series have shown that neither preoperative location of the
556 testis in unilateral cryptorchidism nor testicular size at orchidopexy is an
557 important factor concerning fertility (180-182).
558 Germ cell number. The most important prognostic indicator of fertility is the
559 number of spermatogonia per cross-sectioned tubule. Usually, a cryptorchid child
560 with fewer than 0.2 spermatogonia per cross-sectioned tubule will have a
561 deficient adult spermiogram and compromised fertility. In unilateral
562 cryptorchidism, prognosis depends on the number of spermatogonia in the
563 contralateral testis. However, if spermatogonia numbers per cross-sectioned
564 tubule in the cryptorchid testis are lower than one percent of the normal value for
565 age, the risk of infertility is 33%. In bilateral cryptorchidism, the risk of infertility
566 reaches 73% and even 100% when spermatogonia numbers in one or both
567 testes are below one percent of normal values (120, 171, 183-186). The number of
568 spermatogonia per cross-sectioned tubule correlates not only with sperm
569 numbers in spermiograms, but also with the volume of surgically-repaired testes,
570 serum levels of inhibin B, and testicular volume reached in adulthood. Testicular
571 volume at infancy is not a reliable parameter to predict testes that will have low
572 germ cell numbers, and thus bad prognosis requiring hormonal treatment. Biopsy
573 with histology is the only reliable method to assess germ cell conditions (187).
574 Postoperative patients who fail to show rising serum levels of inhibin B have low
575 numbers of spermatogonia per cross-sectioned tubule, and a low tubular fertility
576 index (188). In most cases, the volume of the contralateral testis correlates
577 positively with sperm concentration, total number of spermatozoa, and the
578 presence of live and mobile spermatozoa (184, 185). On the other hand, FSH levels
579 are negatively correlated with testicular volume, sperm concentration, and total
580 number of spermatozoa. The perspective of fertility for excryptorchid patients is
581 changing due to testicular sperm extraction (TESE). In a series of 142
582 azoospermic men with history of cryptorchidism, sperm retrieval was performed
583 in 61.9% of them, and in patients with bilateral cryptorchidism the rate of
584 extraction was 63%. Those patients whose FSH is normal and/or whose
585 testicular volume is higher than 10 cm3 have an even better prognosis because
586 the rate of TESE with positive sperm retrieval is 75% (189).
587 Testicular Torsion. Torsion of an intra-abdominal testis was first reported
588 by Gerster in 1898 (190).The risk of torsion of the spermatic cord is ten times
589 higher in undescended testes than in scrotal testes. The absence of
590 gubernaculum, a closed internal inguinal ring, and laxity of the spermatic vessels
591 could be the anatomical bases to explain this form of torsion (191). The cause of
592 the testicular torsion within the inguinal canal is not well understood, since it is
593 frequently associated with a short spermatic cord or a hernia sac that would
594 make torsion more difficult. Abnormal cremaster contraction (192, 193) or an
595 abnormal suspensory system could play a role (194-197). According to some, the
596 contralateral testis should be fixed by orchidopexy if suspensory anomalies are
597 observed (198). The number of testes that can thus be preserved is low because
598 of delays in diagnosis (199-201). Adult testes that were fixed by orchidopexy show
599 calcifications in the tunica albuginea at the point of fixation. These calcifications
600 appear mainly when chromic suture material is used (202), and are not related to
601 the pathological features present in cryptorchid testes at the time of orchidopexy
602 or later. Intra-abdominal testes can also undergo torsion (203).
603 Iatrogenic atrophy. The large number of children subjected to orchidopexy
604 has led to the recognition of postsurgical atrophy. Its frequency is estimated from
605 one to five percent for inguinal canal testes, and 25% for intra-abdominal testes
606 (204) (Fig 38).

607 Psychological problems. The psychological implication of an integral

608 anatomy, including having two testes, should be considered when performing an
609 orchidopexy. Losing one or both testes may disrupt the development of male
610 identity (205). If an orchidectomy is performed in a child, a testicular prosthesis
611 should be considered to avoid psychological trauma, keeping in mind that
612 testicular prostheses should be replaced in adulthood (206). Studies carried out
613 in adults whose testes were surgically descended before puberty revealed a
614 normal male development and behavior. Although these men seem to be
615 sexually less active than controls, this does not seem to be related to either the
616 orchidopexy or the age at which it was performed (207).



619 The term “testicular retraction” designates the ascending mobility of one or
620 both testes to the superficial inguinal pouch (Denis Browne pouch) in response to
621 an active cremasteric reflex (208). This has an estimated incidence in children of
622 3.9%. The cremaster muscle controls testicular temperature and protects the
623 testis from trauma. The cremasteric reflex is the result of contraction of two
624 muscles, the cremaster and the inner oblique muscle, producing elevation of the
625 ipsilateral testis in response to stimulation of a sensitive branch of the
626 genitofemoral nerve. This reflex may be spontaneous or induced by cold (209).
627 The cremasteric reflex is present at birth in almost half of newborns (42.7%). Its
628 percentage decreases at four years of age (38.1%), and increases two-fold from
629 that age to puberty (210, 211).
630 Retractile testes have been considered a) a variant of cryptorchidism (212-
631 214); and b) normal testes that should be excluded from the study of

632 undescended testes pathology (the most accepted concept) (156, 215). Authors
633 supporting the first notion believe that retractile testes are cryptorchid as the
634 result of: 1) a defect in spermatic cord development; 2) a patent, although partly
635 obliterated vaginal process; or 3) a spasm of the cremaster, like that observed in
636 children with cerebral palsy or spastic dysplasia (216). Administration of hCG may
637 be useful to distinguish between retractile and cryptorchid testis, because in most
638 cases only the former descend with this treatment (217, 218). Retractile testes are
639 more frequent in infertile patients with history of cryptorchidism (219).
640 Retractile testes cannot always be mobilized to a low scrotal position (70-
641 75 mm from the pubic tubercle). Retractile testes in school-age children (7-12
642 years old) have a lower volume (1.82 ± 1.41 ml) than normal testes (2.38 ± 1.40
643 mm, p<0.05) (220). Differences in volume can be detected early. The mean
644 volume at the age of six months is 0.36 ml vs. 0.53 ml in control cases (74).
645 Retractile testes have a softer consistency and are prone to undergo upward
646 displacement. Between 2 and 45% of them become an ascending or acquired
647 undescended testis (221), a risk higher in boys under seven years of age, and
648 also when the spermatic cord seems tight or inelastic (222, 223). Retractile testes
649 remain high after the age of six, after which the cremasteric reflex steadily
650 declines (224).
651 Histological studies of infantile retractile testes show a decrease in both
652 tubular diameter and TFI (225-229). Fertility is variable. In some series (230, 231),
653 most adults with retractile testes that descended spontaneously were fertile,
654 whereas in other series (232-235), most patients were infertile.
655 Spermiograms were considered normal in 24% of the patients consulting
656 for infertility. The remaining 76% had abnormalities including oligozoospermia in
657 13%, and severe oligoasthenozoospermia in another 13% (236, 237).

658 Ultrastructural study of spermatozoa reveals a high proportion of round and

659 hyperelongated nuclei, lack of chromatin condensation, and hypoplastic
660 acrosomes.
661 In infertile patients with a history of retractile testes, the most frequent
662 histological testicular pattern is germ cell depletion. This varies in intensity from
663 one testicular lobule to another from seminiferous tubules with slight alterations
664 of the adluminal compartment to Sertoli-cell-only tubules (214, 237) (Fig 39).
665 Three mechanisms have been proposed to explain lesions of retractile
666 testes. The first is an increased suprascrotal temperature 2º C higher than the
667 intrascrotal temperature, although this factor only acts for short periods (238). The
668 second possible mechanism is compression of sperm excretory ducts at two
669 levels, either in the rete testis (caused by the testicular centripetal veins) or in the
670 ductuli efferentes (testicular ascent produces shortening of spermatic cord and
671 testicular rotation). The third mechanism is a primary testicular anomaly, since
672 the histological pattern of testicular atrophy observed in retractile testes is similar
673 to that observed in cryptorchid testes (214).
674 Based on these findings, patients with retractile testes should be
675 examined regularly. If the expected testicular descent does not occur,
676 orchidopexy should be considered (239) even though this does not always result
677 in adequate spermatogenesis (214, 224, 240, 241).


680 Testicular dysgenesis syndrome (TDS) is a relatively recent clinico-
681 pathologic concept attracting attention (10, 242-245). TDS comprises a spectrum of
682 male reproductive disorders including cryptorchidism, hypospadias, poor sperm
683 quality, and testicular cancer, with variable clinical presentations. TDS may result
684 from both genetic and environmental factors causing poor testicular
685 development. The apparent increase in prevalence of cryptorchidism in some
686 areas and the geographic differences suggest that both genetic and
687 environmental factors play a role. Other male reproductive disorders, such as
688 hypospadias, reduced semen quality, and testicular cancer all show similarities
689 with cryptorchidism in their geographical distribution and temporal trends (243).
690 They also share common risk factors which suggest prenatal impairment of
691 testicular development as a common cause.
692 Based on the observation that contralateral descended testes from men
693 with cryptorchidism and/or testicular cancer display dysgenetic features (such as
694 Sertoli-cell-only tubules, MAT, abnormally-developed tubules, microlithiasis,
695 granular changes in Sertoli cells, nodular Leydig cell hyperplasia and CIS), these
696 disorders may share a common embryonal origin, possibly leading to a disruption
697 of Sertoli and/or Leydig cell function.
698 The initial abnormality may be an imbalance between estrogens and
699 androgens during fetal life, specifically related to increased estrogen exposure in
700 utero (23). This hypothesis would be further supported by exposure to
701 environmental toxins, which are potential endocrine disruptors of fetal sexual
702 differentiation by either an estrogenic or antiandrogenic effect (246). Various
703 environmental chemicals such as certain phthalates and pesticides are able to
704 alter endogenous levels of androgens. Estrogens, polychlorinated biphenyls, and
705 polyhalogenated hydrocarbons may also be harmful (247-251). In the case of
706 estrogens, cryptorchidism and hypospadias may be induced by suppressing
707 androgen production or action. Additionally, estrogens can induce cryptorchidism
708 by suppressing insulin-like factor 3 (252-255), as well as testicular cancer (256).
709 Genetic predisposition seems to be present in some cases (257).
710 Prenatal exposure to phthalates (the most abundantly-produced
711 plasticizers which leach out from polyvinyl chloride plastics) shows a negative
712 correlation with serum levels of testosterone and with anogenital distance (258).
713 Although testicular dysgenesis syndrome still raises many epidemiological
714 and pathogenetic questions, it provides a unifying hypothesis, particularly since
715 so little is known about the etiologies of this spectrum (259-261).
720 Fig 1. Longitudinal section from cryptorchid testis and epididymis of a three-
721 year-old child showing scant seminiferous tubules, abundant interstitial
722 connective tissue and abnormal insertion of the epididymis head.
724 Fig 2. Cryptorchidism type I. Testicular parenchyma showing a central relatively
725 straight tubule lacking germ cells, surrounded by tubes with normal numbers of
726 germ cells.
728 Fig 3. Cryptorchidism type II. Approximately half of tubules show reduced
729 caliber and lack germ cells.
731 Fig 4. Cryptorchidism type III. Cross- and oblique sections of Sertoli-cell-only
732 tubules.
734 Fig 5. Cryptorchidism type III in a three-year-old child. Immunohistochemistry is
735 strongly positive for inhibin in Sertoli cells.
737 Fig 6. Multinucleate spermatogonia in a child with cryptorchidism type I.
739 Fig 7. Persistence of immature germ cells in the center or lying on the basement
740 membrane of the tubule in a three-year-old cryptorchid child.
742 Fig 8. Microlith inside ring tubules in a type III cryptorchidism.
744 Fig 9. Ring tubule surrounding loose stroma in a type III cryptorchidism.
746 Fig 10. Cryptorchidism type III. Three tubules with eosinophilic granules in the
747 cytoplasm of Sertoli cells.
749 Fig 11. Cryptorchidism type III. Granular change in Sertoli cells highlighted by
750 immunohistochemistry for CD68.
752 Fig 12. Cryptorchid testis in a 15-year-old boy. Tubules show numerous
753 immature Sertoli cells. Occasional interstitial cells of Leydig are present.
755 Fig 13. Cryptorchid testis at puberty. Two adjacent lobules, one (upper right)
756 with the beginning of pubertal maturation (luminal development, increased
757 number of germinal cells), and another (lower left) with a prepubertal pattern.
759 Fig 14. Pubertal cryptorchid testis. Immunohistochemistry for androgen
760 receptor. Irregular nuclear staining of Sertoli cells reflecting abnormal tubular
761 maturation.
763 Fig 15. Cryptorchid pubertal testis. Immunohistochemistry for muscle specific
764 actin. Note strong staining of myoid cells in areas with more advanced
765 maturation.
767 Fig 16. Pubertal cryptorchid testis from a 15-year-old boy. White septa join the
768 rete testis with the tunica albuginea, separating testicular lobules.
770 Fig 17. Pubertal cryptorchid testis. Testicular lobules appear individualized and
771 separated by expansion of interlobular septa.
773 Fig 18. Post-pubertal cryptorchid testis. Abnormal proliferation of
774 spermatogonia, many of which are multinucleated.
776 Fig 19. Post-pubertal cryptorchid testis. Nineteen-year-old patient with
777 numerous dysgenetic Sertoli cells (pseudostratified epithelium with spherical
778 nuclei and central nucleoli) in Sertoli-only tubules.
780 Fig 20. Post-pubertal cryptorchid testis. Mixed atrophy with seminiferous tubules
781 showing maturation arrest of spermatogonia adjacent to smaller Sertoli-cell-only
782 tubules.
784 Fig 21. Post-pubertal cryptorchid testis. Seminiferous tubules with thickened
785 basement membranes and deficient spermatogenesis. Only spermatogonia and
786 type I spermatocytes (dark round nuclei) are found in some tubules.
788 Fig 22. Post-pubertal cryptorchid testis. Orcein stain showing tubules with
789 partial lack of elastic fibers. Note the elastic lamina in the small arteriole.
791 Fig 23. Post-pubertal cryptorchid testis. Collagen IV staining showing irregular
792 thickening of tubular wall.
794 Fig 24. Post-pubertal cryptorchid testis showing anastomosing Sertoli-cell-only
795 tubules with isolated spermatogonia.
797 Fig 25. Post-pubertal cryptorchid testis. Tubules show thick walls lined by
798 columnar, eosinophilic Sertoli cells with elongated nuclei without post-pubertal
799 maturation.
801 Fig 26. Post-pubertal cryptorchid testis. Sertoli cell nodule underlying the tunica
802 albuginea. It has associated focal Leydig cell hyperplasia.
804 Fig 27. Post-pubertal cryptorchid testis. Sertoli only seminiferous tubules with
805 cells showing spheric nuclei and abundant eosinophilic cytoplasmic granulations.
807 Fig 28. Focal Leydig cell hyperplasia in a cryptorchid testis with Sertoli-only
808 tubules and isolated spermatogonia.
809 Fig 29. Adenomatous hyperplasia of rete testis associated with Leydig cell
810 hyperplasia in a cryptorchid testis.
812 Fig 30. Scrotal testis contralateral to a cryptorchid testis from a patient with
813 infertility. Complete spermatogenesis (although quantitatively abnormal) and
814 Leydig cell hyperplasia are noted.
816 Fig 31. Detail from Figure 30 showing Leydig cells with marked vacuolization
817 and signet-ring morphology.
819 Fig 32. Testis from patient with infertility. Complete spermatogenesis with
820 marked tubular ectasia is found. The testis descended prepubertally.
822 Fig 33. Infertile patient with cryptorchidism treated prepubertally. The testis has
823 mixed atrophy (tubules with spermatogenesis adjacent to Sertoli-only tubules).
825 Fig 34. Cross-section of a seminiferous tubule with hypospermatogenesis.
827 Fig 35. Several seminiferous tubules with dysgenetic Sertoli cells (elongated
828 nuclei and marked cytoplasmic vacuolation) and prominent Leydig cell
829 hyperplasia and hypertrophy.
831 Fig 36. Ductuli efferentes from a cryptorchid testis in an adult with markedly-
832 decreased ductular diameter and intertubular fibrosis.
834 Fig 37. Autopsy specimen from a child with prune-belly syndrome, showing renal
835 dysplasia, urinary tract malformation and cryptorchid testes.
837 Fig 38. Longitudinal section from a cryptorchid testis descended in two stages,
838 showing marked atrophy with extensive areas of fibrosis, possibly of ischemic
839 origin.
841 Fig 39. Two central tubules showing only Sertoli cells in an infertile patient. He
842 had a history of retractile testis.
844 Table 1
846 Classification of histological lesions in prepubertal cryptorchid testis according to morphometric
847 parameters.
Type of Lesion Spermatogonia
(Incidence) distribution
Slightly decreased
Type I (31%) (90% normal values)
>50% Normal Regular

Markedly decreased
Type II (29%) (90-60% normal values)
30-50% Decreased Irregular

Severely decreased
Type III (40%) (< 60% normal values)
0-30% Very low Irregular

850 MTD: mean tubular diameter; SCN: Sertoli cell number (average Sertoli cell number per cross-
851 sectioned tubule); TFI: tubular fertility index (percentage of germ cell containing tubules).
859 Table 2
861 Post-pubertal evolution of lesions in testes descended in infancy
Type of Lesion Post-pubertal testicular pathology
Type I Adluminal compartment lesions (57%)
Mixed atrophy of the testis (29%)
Basal and adluminal compartment lesions (14%)
Type II Mixed atrophy of the testis (100%)

Type III Mixed atrophy of the testis with spermatogenesis in < 50% tubules (85% of
Sertoli-cell-only tubules (10% of cases)
Hypospermatogenesis + spermatocyte I sloughing (5% of cases)
865 References
867 1. Scorer CG. The Descent of the Testis. Arch Dis Child. 1964;39:605-9.
868 2. Thonneau PF, Gandia P, Mieusset R. Cryptorchidism: incidence, risk factors, and potential role of
869 environment; an update. J Androl. 2003;24(2):155-62.
870 3. Cryptorchidism: an apparent substantial increase since 1960. John Radcliffe Hospital
871 Cryptorchidism Study Group. Br Med J (Clin Res Ed). 1986;293(6559):1401-4.
872 4. Cryptorchidism: a prospective study of 7500 consecutive male births, 1984-8. John Radcliffe
873 Hospital Cryptorchidism Study Group. Arch Dis Child. 1992;67(7):892-9.
874 5. Virtanen HE, Bjerknes R, Cortes D, Jorgensen N, Rajpert-De Meyts E, Thorsson AV, et al.
875 Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatr. 2007;96(5):611-6.
876 6. Scorer CG, Farrington GH. Congenital deformities of the testis and epididymis. New York:
877 Appleton-Century-Crofts; 1971. p. 136-46
878 .
879 7. Carragher AM, McLean RD. Familial bilateral cryptorchidism. Br J Clin Pract. 1990;44(12):688-
880 9.
881 8. Suetomi T, Kawai K, Sekido N, Kikuchi K, Takeshima H, Akaza H. Testicular cancers occurring
882 in brothers with cryptorchism. Int J Urol. 2002;9(1):67-70.
883 9. Main KM, Skakkebaek NE, Virtanen HE, Toppari J. Genital anomalies in boys and the
884 environment. Best Pract Res Clin Endocrinol Metab. 2010;24(2):279-89.
885 10. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly
886 common developmental disorder with environmental aspects. Hum Reprod. 2001;16(5):972-8.
887 11. Nemec SF, Nemec U, Brugger PC, Bettelheim D, Weber M, Graham JM, Jr., et al. Male genital
888 abnormalities in intrauterine growth restriction. Prenatal diagnosis. 2012;32(5):427-31.
889 12. Akre O, Lipworth L, Cnattingius S, Sparen P, Ekbom A. Risk factor patterns for cryptorchidism
890 and hypospadias. Epidemiology. 1999;10(4):364-9.
891 13. Berkowitz GS, Lapinski RH, Godbold JH, Dolgin SE, Holzman IR. Maternal and neonatal risk
892 factors for cryptorchidism. Epidemiology. 1995;6(2):127-31.
893 14. Hjertkvist M, Damber JE, Bergh A. Cryptorchidism: a registry based study in Sweden on some
894 factors of possible aetiological importance. J Epidemiol Community Health. 1989;43(4):324-9.
895 15. Weidner IS, Moller H, Jensen TK, Skakkebaek NE. Risk factors for cryptorchidism and
896 hypospadias. J Urol. 1999;161(5):1606-9.
897 16. Adesanya OA, Ademuyiwa AO, Bode CO, Adeyomoye AA. Diagnostic value of high resolution
898 ultrasound in localisation of the undescended testis in children. African journal of paediatric surgery :
899 AJPS. 2013;10(2):127-30.
900 17. Tasian GE, Copp HL, Baskin LS. Diagnostic imaging in cryptorchidism: utility, indications, and
901 effectiveness. J Pediatr Surg. 2011;46(12):2406-13.
902 18. Ferlin A, Zuccarello D, Zuccarello B, Chirico MR, Zanon GF, Foresta C. Genetic alterations
903 associated with cryptorchidism. JAMA. 2008;300(19):2271-6.
904 19. Hutson JM, Hasthorpe S, Heyns CF. Anatomical and functional aspects of testicular descent and
905 cryptorchidism. Endocr Rev. 1997;18(2):259-80.
906 20. Pardo-Mindan FJ, Vargas Torcal F, Garcia Julian G, Virto Ruiz MT. Letter: Familial
907 cryptorchidism. Pediatrics. 1975;56(4):616.
908 21. Husmann DA, Levy JB. Current concepts in the pathophysiology of testicular undescent. Urology.
909 1995;46(2):267-76.
910 22. Wiener JS, Marcelli M, Gonzales ET, Jr., Roth DR, Lamb DJ. Androgen receptor gene alterations
911 are not associated with isolated cryptorchidism. J Urol. 1998;160(3 Pt 1):863-5.
912 23. Sharpe RM, Skakkebaek NE. Are oestrogens involved in falling sperm counts and disorders of the
913 male reproductive tract? Lancet. 1993;341(8857):1392-5.
914 24. Hadziselimovic F, Geneto R, Emmons LR. Elevated placental estradiol: a possible etiological
915 factor of human cryptorchidism. J Urol. 2000;164(5):1694-5.
916 25. Hutson JM, Hasthorpe S. Abnormalities of testicular descent. Cell Tissue Res. 2005;322(1):155-8.
917 26. Guven A, Kogan BA. Undescended testis in older boys: further evidence that ascending testes are
918 common. J Pediatr Surg. 2008;43(9):1700-4.
919 27. Hack WW, Sijstermans K, van Dijk J, van der Voort-Doedens LM, de Kok ME, Hobbelt-Stoker
920 MJ. Prevalence of acquired undescended testis in 6-year, 9-year and 13-year-old Dutch schoolboys. Arch
921 Dis Child. 2007;92(1):17-20.
922 28. Eardley I, Saw KC, Whitaker RH. Surgical outcome of orchidopexy. II. Trapped and ascending
923 testes. Br J Urol. 1994;73(2):204-6.
924 29. Colodny AH. Iatrogenic ascent of the testis: an underrecognized complication of inguinal hernia
925 operation in children. Br J Urol. 1994;74(4):531-2.
926 30. Kaplan GW. Iatrogenic cryptorchidism resulting from hernia repair. Surg Gynecol Obstet.
927 1976;142(5):671-2.
928 31. Surana R, Puri P. Iatrogenic ascent of the testis: an under-recognized complication of inguinal
929 hernia operation in children. Br J Urol. 1994;73(5):580-1.
930 32. Hack WW, Goede J, van der Voort-Doedens LM, Meijer RW. Acquired undescended testis:
931 putting the pieces together. Int J Androl. 2012;35(1):41-5.
932 33. Hack WW, van der Voort-Doedens LM, Goede J, van Dijk JM, Meijer RW, Sijstermans K.
933 Natural history and long-term testicular growth of acquired undescended testis after spontaneous descent or
934 pubertal orchidopexy. BJU Int. 2010;106(7):1052-9.
935 34. Bonney T, Hutson J, Southwell B, Newgreen D. Update on congenital versus acquired
936 undescended testes: incidence, diagnosis and management. ANZ journal of surgery. 2008;78(11):1010-3.
937 35. Gracia J, Navarro E, Guirado F, Pueyo C, Ferrandez A. Spontaneous ascent of the testis. Br J
938 Urol. 1997;79(1):113-5.
939 36. Myers NA, Officer CB. Undescended testis: congenital or acquired? Aust Paediatr J.
940 1975;11(2):76-80.
941 37. Clarnette TD, Rowe D, Hasthorpe S, Hutson JM. Incomplete disappearance of the processus
942 vaginalis as a cause of ascending testis. J Urol. 1997;157(5):1889-91.
943 38. Shono T, Zakaria O, Imajima T, Suita S. Does proximal genitofemoral nerve division induce
944 testicular maldescent or ascent in the rat? BJU Int. 1999;83(3):323-6.
945 39. Docimo SG. Testicular descent and ascent in the first year of life. Urology. 1996;48(3):458-60.
946 40. Atwell JD. Ascent of the testis: fact or fiction. Br J Urol. 1985;57(4):474-7.
947 41. Wright JE. Testes do ascend. Pediatri Surg Int. 1989;4:269-72.
948 42. Rabinowitz R, Hulbert WC, Jr. Late presentation of cryptorchidism: the etiology of testicular re-
949 ascent. J Urol. 1997;157(5):1892-4.
950 43. Tasian GE, Zaid H, Cabana MD, Baskin LS. Proximal hypospadias and risk of acquired
951 cryptorchidism. J Urol. 2010;184(2):715-20.
952 44. Jedrzejewski G, Wozniak MM, Madej T, Kryza R, Zielonka-Lamparska E, Wieczorek AP. The
953 differences in testicular volumes in boys 8-36 months old with undescended, retractile and hydrocele testis-
954 -usefulness of scrotal screening ultrasound. Early human development. 2012;88(3):185-9.
955 45. Nistal M, Paniagua R. Testicular biopsy. Contemporary interpretation. Urol Clin North Am.
956 1999;26(3):555-93, vi.
957 46. Hadziselimovic F, Hocht B, Herzog B, Buser MW. Infertility in cryptorchidism is linked to the
958 stage of germ cell development at orchidopexy. Horm Res. 2007;68(1):46-52.
959 47. Huff DS, Hadziselimovic F, Snyder HM, 3rd, Duckett JW, Keating MA. Postnatal testicular
960 maldevelopment in unilateral cryptorchidism. J Urol. 1989;142(2 Pt 2):546-8; discussion 72.
961 48. Rusnack SL, Wu HY, Huff DS, Snyder HM, 3rd, Zderic SA, Carr MC, et al. The ascending testis
962 and the testis undescended since birth share the same histopathology. J Urol. 2002;168(6):2590-1.
963 49. Nistal M, Paniagua R, Diez-Pardo JA. Histologic classification of undescended testes. Hum
964 Pathol. 1980;11(6):666-74.
965 50. Cortes D, Thorup J, Visfeldt J. Multinucleated spermatogonia in cryptorchid boys: a possible
966 association with an increased risk of testicular malignancy later in life? APMIS. 2003;111(1):25-30;
967 discussion 1.
968 51. Huff DS, Fenig DM, Canning DA, Carr MG, Zderic SA, Snyder HM, 3rd. Abnormal germ cell
969 development in cryptorchidism. Horm Res. 2001;55(1):11-7.
970 52. Santamaria L, Martinez-Onsurbe P, Paniagua R, Nistal M. Laminin, type IV collagen, and
971 fibronectin in normal and cryptorchid human testes. An immunohistochemical study. Int J Androl.
972 1990;13(2):135-46.
973 53. AbouZeid AA, Mousa MH, Soliman HA, Hamza AF, Hay SA. Intra-abdominal testis: histological
974 alterations and significance of biopsy. J Urol. 2011;185(1):269-74.
975 54. Giachini C, Nuti F, Marinari E, Forti G, Krausz C. Partial AZFc deletions in infertile men with
976 cryptorchidism. Hum Reprod. 2007;22(9):2398-403.
977 55. Yoshida T, Ohno K, Morotomi Y, Nakamura T, Azuma T, Yamada H, et al. Clinical and
978 pathological features of ascending testis. Osaka City Med J. 2009;55(2):81-7.
979 56. Mayr J, Rune GM, Holas A, Schimpl G, Schmidt B, Haberlik A. Ascent of the testis in children.
980 Eur J Pediatr. 1995;154(11):893-5.
981 57. Imthurn T, Hadziselimovic F, Herzog B. Impaired germ cells in secondary cryptorchid testis after
982 herniotomy. J Urol. 1995;153(3 Pt 1):780-1.
983 58. Nistal M, Paniagua R, Abaurrea MA, Santamaria L. Hyperplasia and the immature appearance of
984 Sertoli cells in primary testicular disorders. Hum Pathol. 1982;13(1):3-12.
985 59. Regadera J, Martinez-Garcia F, Gonzalez-Peramato P, Serrano A, Nistal M, Suarez-Quian C.
986 Androgen receptor expression in sertoli cells as a function of seminiferous tubule maturation in the human
987 cryptorchid testis. J Clin Endocrinol Metab. 2001;86(1):413-21.
988 60. Lackgren G, Ploen L. The morphology of the human undescended testis with special reference to
989 the Sertoli cell and puberty. Int J Androl. 1984;7(1):23-38.
990 61. Rogatsch H, Jezek D, Hittmair A, Mikuz G, Feichtinger H. Expression of vimentin, cytokeratin,
991 and desmin in Sertoli cells of human fetal, cryptorchid, and tumour-adjacent testicular tissue. Virchows
992 Arch. 1996;427(5):497-502.
993 62. Gotoh M, Miyake K, Mitsuya H. Elastic fibers in tunica propria of undescended and contralateral
994 scrotal testes from cryptorchid patients. Urology. 1987;30(4):359-63.
995 63. Maekawa M, Kazama H, Kamimura K, Nagano T. Changes in the arrangement of actin filaments
996 in myoid cells and Sertoli cells of rat testes during postnatal development and after experimental
997 cryptorchidism. Anat Rec. 1995;241(1):59-69.
998 64. Hedinger E. Histopathology of undescended testes. Eur J Pediatr. 1982;139(4):266-71.
999 65. Nistal M, Jimenez-Heffernan JA. Rete testis dysgenesis. A characteristic lesion of undescended
1000 testes. Arch Pathol Lab Med. 1997;121(12):1259-64.
1001 66. Foresta C, Ferlin A, Garolla A, Milani C, Oliva G, Rossato M. Functional and cytologic features
1002 of the contralateral testis in cryptorchidism. Fertil Steril. 1996;66(4):624-9.
1003 67. Vinardi S, Magro P, Manenti M, Lala R, Costantino S, Cortese MG, et al. Testicular function in
1004 men treated in childhood for undescended testes. J Pediatr Surg. 2001;36(2):385-8.
1005 68. Nistal M, Riestra ML, Paniagua R. Correlation between testicular biopsies (prepubertal and
1006 postpubertal) and spermiogram in cryptorchid men. Hum Pathol. 2000;31(9):1022-30.
1007 69. Nistal M, Paniagua R, Riestra ML, Reyes-Mugica M, Cajaiba MM. Bilateral prepubertal testicular
1008 biopsies predict significance of cryptorchidism-associated mixed testicular atrophy, and allow assessment
1009 of fertility. Am J Surg Pathol. 2007;31(8):1269-76.
1010 70. Elder JS. Epididymal anomalies associated with hydrocele/hernia and cryptorchidism:
1011 implications regarding testicular descent. J Urol. 1992;148(2 Pt 2):624-6.
1012 71. Mollaeian M, Mehrabi V, Elahi B. Significance of epididymal and ductal anomalies associated
1013 with undescended testis: study in 652 cases. Urology. 1994;43(6):857-60.
1014 72. Tekgül S, Dogan HS, Hoebeke P, Kocvara R, Nijman JM, Radmayr C, et al. Guidelines on
1015 Paediatric Urology 2014 [cited 2014]. Available from:
1017 73. Dadfar MR. Orchidopexy for retractile testes in infertile men: a prospective clinical study. Urol J.
1018 2007;4(3):164-8.
1019 74. Kollin C, Karpe B, Hesser U, Granholm T, Ritzen EM. Surgical treatment of unilaterally
1020 undescended testes: testicular growth after randomization to orchiopexy at age 9 months or 3 years. J Urol.
1021 2007;178(4 Pt 2):1589-93; discussion 93.
1022 75. McCabe JE, Kenny SE. Orchidopexy for undescended testis in England: is it evidence based? J
1023 Pediatr Surg. 2008;43(2):353-7.
1024 76. Park KH, Lee JH, Han JJ, Lee SD, Song SY. Histological evidences suggest recommending
1025 orchiopexy within the first year of life for children with unilateral inguinal cryptorchid testis. Int J Urol.
1026 2007;14(7):616-21.
1027 77. Ritzen EM. Undescended testes: a consensus on management. Eur J Endocrinol. 2008;159 Suppl
1028 1:S87-90.
1029 78. Golabek T, Kiely E. Patterns of referral and treatment of undescended testis: a 12-year experience
1030 in a single centre. Ir J Med Sci. 2010;179(4):511-4.
1031 79. Mathers MJ, Sperling H, Rubben H, Roth S. The undescended testis: diagnosis, treatment and
1032 long-term consequences. Dtsch Arztebl Int. 2009;106(33):527-32.
1033 80. Thorsson AV, Christiansen P, Ritzen M. Efficacy and safety of hormonal treatment of
1034 cryptorchidism: current state of the art. Acta Paediatr. 2007;96(5):628-30.
1035 81. Hadziselimovic F, Zivkovic D. Is the prohibition of hormonal treatment for cryptorchidism, as
1036 suggested by the Nordic consensus group, justifiable? Acta Paediatr. 2007;96(9):1368-9; author reply 70.
1037 82. Strittmatter T. Testicular autotransplantation - the Monchengladbach experience. Horm Res.
1038 2001;55(1):51.
1039 83. Zivkovic D, Bica DT, Hadziselimovic F. Relationship between adult dark spermatogonia and
1040 secretory capacity of Leydig cells in cryptorchidism. BJU Int. 2007;100(5):1147-9; discussion 9.
1041 84. Cortes D, Thorup JM, Visfeldt J. Cryptorchidism: aspects of fertility and neoplasms. A study
1042 including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for
1043 cryptorchidism. Horm Res. 2001;55(1):21-7.
1044 85. Silber SJ, Kelly J. Successful autotransplantation of an intra-abdominal testis to the scrotum by
1045 microvascular technique. J Urol. 1976;115(4):452-4.
1046 86. Melchior D, Kaefer M, Eugster E, Havlik R. A novel microvascular approach to treatment of the
1047 high undescended testicle. J Pediatr Surg. 2002;37(10):1501-3.
1048 87. Tackett LD, Wacksman J, Billmire D, Sheldon CA, Minevich E. The high intra-abdominal testis:
1049 technique and long-term success of laparoscopic testicular autotransplantation. J Endourol. 2002;16(6):359-
1050 61.
1051 88. Bukowski TP, Wacksman J, Billmire DA, Lewis AG, Sheldon CA. Testicular autotransplantation:
1052 a 17-year review of an effective approach to the management of the intra-abdominal testis. J Urol.
1053 1995;154(2 Pt 1):558-61.
1054 89. MacMahon RA, O'Brien BM, Aberdeen J, Richardson W, Cussen LJ. Results of the use of
1055 autotransplantation of the intraabdominal testis using microsurgical vascular anastomosis. J Pediatr Surg.
1056 1980;15(1):92-6.
1057 90. O'Brien BM, Rao VK, MacLeod AM, Morrison WA, MacMahon RA. Microvascular testicular
1058 transfer. Plast Reconstr Surg. 1983;71(1):87-91.
1059 91. Eijsbouts SW, de Muinck Keizer-Schrama SM, Hazebroek FW. Further evidence for spontaneous
1060 descent of acquired undescended testes. J Urol. 2007;178(4 Pt 2):1726-9.
1061 92. Meij-de Vries A, Goede J, van der Voort L, Heij HA, Meijer RW, Hack WW. Long-term testicular
1062 position and growth of acquired undescended testis after prepubertal orchidopexy. J Pediatr Surg.
1063 2012;47(4):727-35.
1064 93. Elder JS. Laparoscopy for impalpable testes: significance of the patent processus vaginalis. J Urol.
1065 1994;152(2 Pt 2):776-8.
1066 94. He D, Lin T, Wei G, Li X, Liu J, Hua Y, et al. Laparoscopic orchiopexy for treating inguinal
1067 canalicular palpable undescended testis. J Endourol. 2008;22(8):1745-9.
1068 95. Varela Cives R, Bautista Casasnovas A, Alonso Martin A, Pombo Arias M, Tojo Sierra R. The
1069 influence of patency of the vaginal process on the efficacy of hormonal treatment of cryptorchidism. Eur J
1070 Pediatr. 1996;155(11):932-6.
1071 96. Aggarwal H, Kogan BA, Feustel PJ. One third of patients with a unilateral palpable undescended
1072 testis have a contralateral patent processus. J Pediatr Surg. 2012;47(9):1711-5.
1073 97. Patel RP, Kolon TF, Huff DS, Carr MC, Zderic SA, Canning DA, et al. Cryptorchid testis
1074 histopathology in myelomeningocele patients. J Pediatr Urol. 2008;4(6):434-7.
1075 98. Yardley IE, Bostock E, Jones MO, Turnock RR, Corbett HJ, Losty PD. Congenital abdominal
1076 wall defects and testicular maldescent--a 10-year single-center experience. J Pediatr Surg.
1077 2012;47(6):1118-22.
1078 99. Hill SJ, Durham MM. Management of cryptorchidism and gastroschisis. J Pediatr Surg.
1079 2011;46(9):1798-803.
1080 100. Cortes D, Thorup JM, Nielsen OH, Beck BL. Cryptorchidism in boys with imperforate anus. J
1081 Pediatr Surg. 1995;30(4):631-5.
1082 101. Misra D, Mushtaq I, Drake DP, Kiely EM, Spitz L. Associated urologic anomalies in low
1083 imperforate anus are capable of causing significant morbidity: a 15-year experience. Urology.
1084 1996;48(2):281-3.
1085 102. Mathews RI, Perlman E, Marsh DW, Gearhart JP. Gonadal morphology in cloacal exstrophy:
1086 implications in gender assignment. BJU Int. 1999;84(1):99-100.
1087 103. Nistal M, Castillo MC, Regadera J, Garcia-Cabezas MA. Adenomatous hyperplasia of the rete
1088 testis. A review and report of new cases. Histol Histopathol. 2003;18(3):741-52.
1089 104. Taskinen S, Hovatta O, Wikstrom S. Early treatment of cryptorchidism, semen quality and
1090 testicular endocrinology. J Urol. 1996;156(1):82-4.
1091 105. Johansen TE. Anatomy of the testis and epididymis in cryptorchidism. Andrologia.
1092 1987;19(5):565-9.
1093 106. Koff WJ, Scaletscky R. Malformations of the epididymis in undescended testis. J Urol.
1094 1990;143(2):340-3.
1095 107. Marshall FF, Elder JS. Cryptorchidism and related anomalies. New York: Preger; 1982.
1096 108. Pippi-Salle JL, Langer J, Favorito LA. Unilateral renal agenesia associated with partial epididymis
1097 and vas deferens agenesia in a patient with abdominal testicle. Int Braz J Urol. 2006;32(2):208-10.
1098 109. De Miguel MP, Marino JM, Gonzalez-Peramato P, Nistal M, Regadera J. Epididymal growth and
1099 differentiation are altered in human cryptorchidism. J Androl. 2001;22(2):212-25.
1100 110. Barthold JS, Redman JF. Association of epididymal anomalies with patent processus vaginalis in
1101 hernia, hydrocele and cryptorchidism. J Urol. 1996;156(6):2054-6.
1102 111. Favorito LA, Sampaio FJ, Javaroni V, Cardoso LE, Costa WS. Proximal insertion of
1103 gubernaculum testis in normal human fetuses and in boys with cryptorchidism. J Urol. 2000;164(3 Pt
1104 1):792-4.
1105 112. Gutierrez A, Campos A, Canizares FJ, Crespo PV, Sanchez C. Anatomical and clinical correlation
1106 with histological and histometric patterns in cryptorchism. Br J Urol. 1993;72(4):506-9.
1107 113. Riebel T, Herrmann C, Wit J, Sellin S. Ultrasonographic late results after surgically treated
1108 cryptorchidism. Pediatr Radiol. 2000;30(3):151-5.
1109 114. Sasagawa I, Yamaguchi O, Shiraiwa Y, Nakada T. Klinefelter's syndrome associated with
1110 unilateral cryptorchidism in childhood. Urol Int. 1991;47(3):178-80.
1111 115. Yamaguchi T, Kitada S, Osada Y. Chromosomal anomalies in cryptorchidism and hypospadias.
1112 Urol Int. 1991;47(2):60-3.
1113 116. Kaefer M, Diamond D, Hendren WH, Vemulapalli S, Bauer SB, Peters CA, et al. The incidence of
1114 intersexuality in children with cryptorchidism and hypospadias: stratification based on gonadal palpability
1115 and meatal position. J Urol. 1999;162(3 Pt 2):1003-6; discussion 6-7.
1116 117. Rajfer J, Walsh PC. The incidence of intersexuality in patients with hypospadias and
1117 cryptorchidism. J Urol. 1976;116(6):769-70.
1118 118. Wong CA, Cuda S, Kirsch A. A review of the urologic manifestations of Beckwith-Wiedemann
1119 syndrome. J Pediatr Urol. 2011;7(2):140-4.
1120 119. Boulas MM. Recognition of caudal regression syndrome. Adv Neonatal Care. 2009;9(2):61-9;
1121 quiz 70-1.
1122 120. Cortes D, Thorup JM, Beck BL, Visfeldt J. Cryptorchidism as a caudal developmental field defect.
1123 A new description of cryptorchidism associated with malformations and dysplasias of the kidneys, the
1124 ureters and the spine from T10 to S5. APMIS. 1998;106(10):953-8.
1125 121. Diao B, Diallo Y, Fall PA, Ngom G, Fall B, Ndoye AK, et al. [Prune Belly syndrome:
1126 epidemiologic, clinic and therapeutic aspects]. Prog Urol. 2008;18(7):470-4.
1127 122. Rich MA. The prune belly syndrome: AUA Update Series XI. Bellaire, TX: AUA Office of
1128 Education; 1992. p. 130-5.
1129 123. Routh JC, Huang L, Retik AB, Nelson CP. Contemporary epidemiology and characterization of
1130 newborn males with prune belly syndrome. Urology. 2010;76(1):44-8.
1131 124. Granberg CF, Harrison SM, Dajusta D, Zhang S, Hajarnis S, Igarashi P, et al. Genetic basis of
1132 prune belly syndrome: screening for HNF1beta gene. J Urol. 2012;187(1):272-8.
1133 125. Metwalley KA, Farghalley HS, Abd-Elsayed AA. Prune belly syndrome in an Egyptian infant
1134 with Down syndrome: a case report. J Med Case Rep. 2008;2:322.
1135 126. Shah D, Sharma S, Faridi MM, Mishra K. VACTERL association with Prune-Belly syndrome.
1136 Indian Pediatr. 2004;41(8):845-7.
1137 127. Silengo M, Barberis L, Ferrero GB, Sorasio L, Valenzise M. A possible relationship between
1138 Beckwith-Wiedemann syndrome and prune belly syndrome. Clin Dysmorphol. 2002;11(4):293-4.
1139 128. Stephens FD, Gupta D. Pathogenesis of the prune belly syndrome. J Urol. 1994;152(6 Pt 2):2328-
1140 31.
1141 129. Garcia Luzardo MR, Valenciano Fuente B, Bas Suarez P, Bello Naranjo AM. [Pseudo-Prune-
1142 Belly syndrome: a Prune-Belly without cryptorchidism]. Anales de pediatria (Barcelona, Spain : 2003).
1143 2011;75(1):70-2.
1144 130. Nakayama DK, Harrison MR, Chinn DH, de Lorimier AA. The pathogenesis of prune belly. Am J
1145 Dis Child. 1984;138(9):834-6.
1146 131. Sigel A, Schrott KM. [Congenital megaureter and its implications]. Der Urologe Ausg A.
1147 1982;21(6):312-7.
1148 132. Papantoniou N, Papoutsis D, Daskalakis G, Chatzipapas I, Sindos M, Papaspyrou I, et al. Prenatal
1149 diagnosis of prune-belly syndrome at 13 weeks of gestation: case report and review of literature. J Matern
1150 Fetal Neonatal Med. 2010;23(10):1263-7.
1151 133. Woodhouse CR, Ransley PG, Innes-Williams D. Prune belly syndrome--report of 47 cases. Arch
1152 Dis Child. 1982;57(11):856-9.
1153 134. Orvis BR, Bottles K, Kogan BA. Testicular histology in fetuses with the prune belly syndrome
1154 and posterior urethral valves. J Urol. 1988;139(2):335-7.
1155 135. Massad CA, Cohen MB, Kogan BA, Beckstead JH. Morphology and histochemistry of infant
1156 testes in the prune belly syndrome. J Urol. 1991;146(6):1598-600.
1157 136. Parra RO, Cummings JM, Palmer DC. Testicular seminoma in a long-term survivor of the prune
1158 belly syndrome. European urology. 1991;19(1):79-80.
1159 137. Sayre R, Stephens R, Chonko AM. Prune belly syndrome and retroperitoneal germ cell tumor. The
1160 American journal of medicine. 1986;81(5):895-7.
1161 138. Hall BD. Choanal atresia and associated multiple anomalies. J Pediatr. 1979;95(3):395-8.
1162 139. Hittner HM, Hirsch NJ, Kreh GM, Rudolph AJ. Colobomatous microphthalmia, heart disease,
1163 hearing loss, and mental retardation--a syndrome. Journal of pediatric ophthalmology and strabismus.
1164 1979;16(2):122-8.
1165 140. Pagon RA, Graham JM, Jr., Zonana J, Yong SL. Coloboma, congenital heart disease, and choanal
1166 atresia with multiple anomalies: CHARGE association. J Pediatr. 1981;99(2):223-7.
1167 141. Guyot JP, Gacek RR, DiRaddo P. The temporal bone anomaly in CHARGE association. Arch
1168 Otolaryngol Head Neck Surg. 1987;113(3):321-4.
1169 142. Jongmans MC, Admiraal RJ, van der Donk KP, Vissers LE, Baas AF, Kapusta L, et al. CHARGE
1170 syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2006;43(4):306-14.
1171 143. Vissers LE, van Ravenswaaij CM, Admiraal R, Hurst JA, de Vries BB, Janssen IM, et al.
1172 Mutations in a new member of the chromodomain gene family cause CHARGE syndrome. Nature genetics.
1173 2004;36(9):955-7.
1174 144. Zentner GE, Layman WS, Martin DM, Scacheri PC. Molecular and phenotypic aspects of CHD7
1175 mutation in CHARGE syndrome. Am J Med Genet A. 2010;152A(3):674-86.
1176 145. Sanlaville D, Verloes A. CHARGE syndrome: an update. Eur J Hum Genet. 2007;15(4):389-99.
1177 146. Bergman JE, Bocca G, Hoefsloot LH, Meiners LC, van Ravenswaaij-Arts CM. Anosmia predicts
1178 hypogonadotropic hypogonadism in CHARGE syndrome. J Pediatr. 2011;158(3):474-9.
1179 147. Sullivan KE. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial
1180 Syndrome. Immunology and allergy clinics of North America. 2008;28(2):353-66.
1181 148. Jain S, Kim HG, Lacbawan F, Meliciani I, Wenzel W, Kurth I, et al. Unique phenotype in a
1182 patient with CHARGE syndrome. International journal of pediatric endocrinology. 2011;2011:11.
1183 149. Pinto G, Abadie V, Mesnage R, Blustajn J, Cabrol S, Amiel J, et al. CHARGE syndrome includes
1184 hypogonadotropic hypogonadism and abnormal olfactory bulb development. J Clin Endocrinol Metab.
1185 2005;90(10):5621-6.
1186 150. Ragan DC, Casale AJ, Rink RC, Cain MP, Weaver DD. Genitourinary anomalies in the CHARGE
1187 association. J Urol. 1999;161(2):622-5.
1188 151. Kiely EA. Scientific basis of testicular descent and management implications for cryptorchidism.
1189 Br J Clin Pract. 1994;48(1):37-41.
1190 152. Akre O, Pettersson A, Richiardi L. Risk of contralateral testicular cancer among men with
1191 unilaterally undescended testis: a meta analysis. Int J Cancer. 2009;124(3):687-9.
1192 153. Lip SZ, Murchison LE, Cullis PS, Govan L, Carachi R. A meta-analysis of the risk of boys with
1193 isolated cryptorchidism developing testicular cancer in later life. Arch Dis Child. 2013;98(1):20-6.
1194 154. Giwercman A, Muller J, Skakkeboek NE. Cryptorchidism and testicular neoplasia. Horm Res.
1195 1988;30(4-5):157-63.
1196 155. Moller H, Prener A, Skakkebaek NE. Testicular cancer, cryptorchidism, inguinal hernia, testicular
1197 atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Control.
1198 1996;7(2):264-74.
1199 156. Cheng C, Chan PS. Cryptorchism with a large abdominal mass--a challenge. Br J Urol.
1200 1993;72(6):946-8.
1201 157. Cortes D, Thorup J, Frisch M, Moller H, Jacobsen GK, Beck BL. Examination for intratubular
1202 germ cell neoplasia at operation for undescended testis in boys. J Urol. 1994;151(3):722-5.
1203 158. Berthelsen JG, Skakkebaek NE. Distribution of carcinoma "in situ" in testes from infertile men.
1204 Int J Androl. 1981;Suppl 4:172-84.
1205 159. Pedersen KV, Boiesen P, Zetterlund CG. Experience of screening for carcinoma-in-situ of the
1206 testis among young men with surgically corrected maldescended testes. Int J Androl. 1987;10(1):181-5.
1207 160. Berthelsen JG, Skakkebaek NE, Mogensen P, Sorensen BL. Incidence of carcinoma in situ of
1208 germ cells in contralateral testis of men with testicular tumours. Br Med J. 1979;2(6186):363-4.
1209 161. Parkinson MC, Swerdlow AJ, Pike MC. Carcinoma in situ in boys with cryptorchidism: when can
1210 it be detected? Br J Urol. 1994;73(4):431-5.
1211 162. Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol.
1212 2004;22(1):2-14.
1213 163. Engeler DS, Hosli PO, John H, Bannwart F, Sulser T, Amin MB, et al. Early orchiopexy:
1214 prepubertal intratubular germ cell neoplasia and fertility outcome. Urology. 2000;56(1):144-8.
1215 164. Abratt RP, Reddi VB, Sarembock LA. Testicular cancer and cryptorchidism. Br J Urol.
1216 1992;70(6):656-9.
1217 165. Guminska A, Slowikowska-Hilczer J, Kuzanski W, Sosnowski M, Oszukowska E, Marchlewska
1218 K, et al. Features of impaired seminiferous tubule differentiation are associated with germ cell neoplasia in
1219 adult men surgically treated in childhood because of cryptorchidism. Folia Histochem Cytobiol. 2007;45
1220 Suppl 1:S163-8.
1221 166. Gauwitz MD, Zagars GK. Treatment of seminoma arising in cryptorchid testes. Int J Radiat Oncol
1222 Biol Phys. 1992;24(1):153-9.
1223 167. Hutson JM. Journal of Pediatric Surgery-Sponsored Fred McLoed Lecture. Undescended testis:
1224 the underlying mechanisms and the effects on germ cells that cause infertility and cancer. J Pediatr Surg.
1225 2013;48(5):903-8.
1226 168. WHO. International Journal of Andrology: Supplement 7: Scriptor; 1987.
1227 169. Carizza C, Antiba A, Palazzi J, Pistono C, Morana F, Alarcon M. Testicular maldescent and
1228 infertility. Andrologia. 1990;22(3):285-8.
1229 170. Robin G, Boitrelle F, Marcelli F, Colin P, Leroy-Martin B, Mitchell V, et al. [Cryptorchidism:
1230 from physiopathology to infertility]. Gynecol Obstet Fertil. 2010;38(10):588-99.
1231 171. Cortes D, Thorup J. Histology of testicular biopsies taken at operation for bilateral maldescended
1232 testes in relation to fertility in adulthood. Br J Urol. 1991;68(3):285-91.
1233 172. Puri P, O'Donnell B. Semen analysis of patients who had orchidopexy at or after seven years of
1234 age. Lancet. 1988;2(8619):1051-2.
1235 173. Puri P, O'Donnell B. Semen analysis in patients operated on for impalpable testes. Br J Urol.
1236 1990;66(6):646-7.
1237 174. Kogan SJ. Fertility in cryptorchidism. An overview in 1987. Eur J Pediatr. 1987;146 Suppl 2:S21-
1238 4.
1239 175. Ponchietti R, Grechi G. Fertility in unilateral cryptorchidism: review of 104 cases. Acta Eur Fertil.
1240 1986;17(4):277-8.
1241 176. Lee PA, Coughlin MT. Fertility after bilateral cryptorchidism. Evaluation by paternity, hormone,
1242 and semen data. Horm Res. 2001;55(1):28-32.
1243 177. Coughlin MT, O'Leary LA, Songer NJ, Bellinger MF, LaPorte RE, Lee PA. Time to conception
1244 after orchidopexy: evidence for subfertility? Fertil Steril. 1997;67(4):742-6.
1245 178. Mahmoud AM, Comhaire FH, Abdel-Rahim DE, Abdel-Hafez KM. Conception rates and assisted
1246 reproduction in subfertility due to unilateral cryptorchidism. Andrologia. 1996;28(3):141-4.
1247 179. Smith EM, Dahms BB, Elder JS. Influence of vas deferens mobilization on rat fertility:
1248 implications regarding orchiopexy. J Urol. 1993;150(2 Pt 2):663-6.
1249 180. Lee PA, Coughlin MT, Bellinger MF. Paternity and hormone levels after unilateral
1250 cryptorchidism: association with pretreatment testicular location. J Urol. 2000;164(5):1697-701.
1251 181. Lee PA, Coughlin MT, Bellinger MF. No relationship of testicular size at orchiopexy with fertility
1252 in men who previously had unilateral cryptorchidism. J Urol. 2001;166(1):236-9.
1253 182. Wilkerson ML, Bartone FF, Fox L, Hadziselimovic F. Fertility potential: a comparison of intra-
1254 abdominal and intracanalicular testes by age groups in children. Horm Res. 2001;55(1):18-20.
1255 183. Cendron M, Keating MA, Huff DS, Koop CE, Snyder HM, 3rd, Duckett JW. Cryptorchidism,
1256 orchiopexy and infertility: a critical long-term retrospective analysis. J Urol. 1989;142(2 Pt 2):559-62;
1257 discussion 72.
1258 184. Cortes D, Thorup JM, Lindenberg S. Fertility potential after unilateral orchiopexy: simultaneous
1259 testicular biopsy and orchiopexy in a cohort of 87 patients. J Urol. 1996;155(3):1061-5.
1260 185. Cortes D, Thorup JM, Lindenberg S. Fertility potential after unilateral orchiopexy: an age
1261 independent risk of subsequent infertility when biopsies at surgery lack germ cells. J Urol.
1262 1996;156(1):217-20.
1263 186. Hadziselimovic F, Hecker E, Herzog B. The value of testicular biopsy in cryptorchidism. Urol
1264 Res. 1984;12(3):171-4.
1265 187. Noh PH, Cooper CS, Snyder HM, 3rd, Zderic SA, Canning DA, Huff DS. Testicular volume does
1266 not predict germ cell count in patients with cryptorchidism. J Urol. 2000;163(2):593-6.
1267 188. Irkilata HC, Yildirim I, Onguru O, Aydur E, Musabak U, Dayanc M. The influence of orchiopexy
1268 on serum inhibin B level: relationship with histology. J Urol. 2004;172(6 Pt 1):2402-5; discussion 5.
1269 189. Marcelli F, Robin G, Lefebvre-Khalil V, Marchetti C, Lemaitre L, Mitchell V, et al. [Results of
1270 surgical testicular sperm extractions (TESE) in a population of azoospermic patients with a history of
1271 cryptorchidism based on a 10-year experience of 142 patients]. Prog Urol. 2008;18(10):657-62.
1272 190. Gerster AG. Torsion of the testis. Ann Surg. 1898;27:649.
1273 191. Papparella A, Nino F, Coppola S, Parmeggiani P. An unusual case of intra-abdominal testicular
1274 torsion: role of laparoscopy. African journal of paediatric surgery : AJPS. 2013;10(1):29-31.
1275 192. Candocia FJ, Sack-Solomon K. An infant with testicular torsion in the inguinal canal. Pediatr
1276 Radiol. 2003;33(10):722-4.
1277 193. Pogorelic Z, Mrklic I, Juric I, Biocic M, Furlan D. Testicular torsion in the inguinal canal in
1278 children. J Pediatr Urol. 2013;9(6 Pt A):793-7.
1279 194. Haynes BE, Bessen HA, Haynes VE. The diagnosis of testicular torsion. JAMA.
1280 1983;249(18):2522-7.
1281 195. Krarug T. The testis after torsion. Br J Urol. 1978;50:43-6.
1282 196. Ransler CW, 3rd, Allen TD. Torsion of the spermatic cord. Urol Clin North Am. 1982;9(2):245-
1283 50.
1284 197. Williamson RC. Torsion of the testis and allied conditions. Br J Surg. 1976;63(6):465-76.
1285 198. Andersen L, Wille-Jorgensen PA. Torsion of the testis. A 5-year material. Scand J Urol Nephrol.
1286 1990;24(2):91-3.
1287 199. Knight RM, Cuenca PJ. Torsion of undescended testis in a 14-month-old child refusing to bear
1288 weight. The western journal of emergency medicine. 2011;12(4):515-9.
1289 200. Singal AK, Jain V, Dubey M, Deshpande P. Undescended testis and torsion: is the risk
1290 understated? Arch Dis Child. 2013;98(1):77-9.
1291 201. Zilberman D, Winkler H, Kleinmann N, Raviv G, Chertin B, Ramon J, et al. Testicular prosthesis
1292 insertion following testicular loss or atrophy during early childhood--technical aspects and evaluation of
1293 patient satisfaction. J Pediatr Urol. 2007;3(6):461-5.
1294 202. Ward JF, Cilento BG, Jr., Kaplan GW, Velling TE, Puckett M, Stock J. The ultrasonic description
1295 of postpubertal testicles in men who have undergone prepubertal orchiopexy for cryptorchidism. J Urol.
1296 2000;163(5):1448-50.
1297 203. Lee KF, Tang YC, Leong HT. Emergency laparoscopic orchidectomy for torsion of intra-
1298 abdominal testis: a case report. J R Coll Surg Edinb. 2001;46(2):110-2.
1299 204. Cortes D. Cryptorchidism--aspects of pathogenesis, histology and treatment. Scand J Urol Nephrol
1300 Suppl. 1998;196:1-54.
1301 205. Blos P. Comments on the psychological consquences of cryptorchidism. Psychoanal Study Child.
1302 1960;15:395-429.
1303 206. Martinez Y, Millan A, Gilabert R, Delgado L, De Agustin JC. [Study of satisfaction of testicular
1304 prosthesis implantation in children]. Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia
1305 Pediatrica. 2012;25(1):20-3.
1306 207. Taskinen S, Hovatta O, Wikstrom S. Sexual development in patients treated for cryptorchidism.
1307 Scand J Urol Nephrol. 1997;31(4):361-4.
1308 208. Schoorl M. Classification and diagnosis of undescended testes. Eur J Pediatr. 1982;139(4):253-4.
1309 209. Sugiyama T, Kiwamoto H, Ohnishi N, Esa A, Park YC, Kurita T. Burst activities of cremasteric
1310 motor units. Int Urol Nephrol. 1994;26(6):681-9.
1311 210. Bingol-Kologlu M, Tanyel FC, Anlar B, Buyukpamukcu N. Cremasteric reflex and retraction of a
1312 testis. J Pediatr Surg. 2001;36(6):863-7.
1313 211. Caesar RE, Kaplan GW. The incidence of the cremasteric reflex in normal boys. J Urol.
1314 1994;152(2 Pt 2):779-80.
1315 212. Alexandre C. Les testicules oscillants. Forme degradee de cryptorchidie? J Gynecol Obstet Biol
1316 Reprod. 1977;6:71-4.
1317 213. Ito H, Kataumi Z, Yanagi S, Kawamura K, Sumiya H, Fuse H, et al. Changes in the volume and
1318 histology of retractile testes in prepubertal boys. Int J Androl. 1986;9(3):161-9.
1319 214. Nistal M, Paniagua R. Infertility in adult males with retractile testes. Fertil Steril. 1984;41(3):395-
1320 403.
1321 215. Huff DS, Hadziselimovic F, Snyder HM, 3rd, Blythe B, Ducket JW. Histologic maldevelopment
1322 of unilaterally cryptorchid testes and their descended partners. Eur J Pediatr. 1993;152 Suppl 2:S11-4.
1323 216. Smith JA, Hutson JM, Beasley SW, Reddihough DS. The relationship between cerebral palsy and
1324 cryptorchidism. J Pediatr Surg. 1989;24(12):1303-5.
1325 217. Dickerman Z, Bauman B, Sandovsky U, Kleinhouse N, Lahmy O, Savir A, et al. Human chorionic
1326 gonadotropin (hCG) treatment in cryptorchidism. Andrologia. 1983;15 Spec No:542-7.
1327 218. Metin A, Kayigil O, Ahmed SI. The efficacy of human chorionic gonadotropin in retractile testis.
1328 Neuro Endocrinol Lett. 2005;26(1):39-42.
1329 219. Mieusset R, Bujan L, Massat G, Mansat A, Pontonnier F. Clinical and biological characteristics of
1330 infertile men with a history of cryptorchidism. Hum Reprod. 1995;10(3):613-9.
1331 220. Inan M, Aydiner CY, Tokuc B, Aksu B, Ayhan S, Ayvaz S, et al. Prevalence of cryptorchidism,
1332 retractile testis and orchiopexy in school children. Urol Int. 2008;80(2):166-71.
1333 221. Stec AA, Thomas JC, DeMarco RT, Pope JCt, Brock JW, 3rd, Adams MC. Incidence of testicular
1334 ascent in boys with retractile testes. J Urol. 2007;178(4 Pt 2):1722-4; discussion 4-5.
1335 222. Agarwal PK, Diaz M, Elder JS. Retractile testis--is it really a normal variant? J Urol.
1336 2006;175(4):1496-9.
1337 223. Bae JJ, Kim BS, Chung SK. Long-term outcomes of retractile testis. Korean journal of urology.
1338 2012;53(9):649-53.
1339 224. Wyllie GG. The retractile testis. Med J Aust. 1984;140(7):403-5.
1340 225. Cinti S, Barbatelli G, Pierleoni C, Caucci M. The normal, cryptorchid and retractile prepuberal
1341 human testis: a comparative morphometric ultrastructural study of 101 cases. Scanning Microsc.
1342 1993;7(1):351-8; discussion 8-62.
1343 226. Han SW, Lee T, Kim JH, Choi SK, Cho NH, Han JY. Pathological difference between retractile
1344 and cryptorchid testes. J Urol. 1999;162(3 Pt 1):878-80.
1345 227. Nistal M, Garcia-Rodeja E, Paniagua R. Granular transformation of Sertoli cells in testicular
1346 disorders. Hum Pathol. 1991;22(2):131-7.
1347 228. Rune GM, Mayr J, Neugebauer H, Anders C, Sauer H. Pattern of Sertoli cell degeneration in
1348 cryptorchid prepubertal testes. Int J Androl. 1992;15(1):19-31.
1349 229. Saito S, Kumamoto Y. The number of spermatogonia in various congenital testicular disorders. J
1350 Urol. 1989;141(5):1166-8.
1351 230. La Scala GC, Ein SH. Retractile testes: an outcome analysis on 150 patients. J Pediatr Surg.
1352 2004;39(7):1014-7.
1353 231. Puri P, Nixon HH. Bilateral retractile testes-subsequent effects on fertility. J Pediatr Surg.
1354 1967;12:563-6.
1355 232. Abyholm T, Oian P, Gordeladze JO. True cryptorchidism and retractile testes in infertile men.
1356 Acta Eur Fertil. 1986;17(1):15-8.
1357 233. Ingerslev HJ, Rasmussen TB, Hostrup H. [Fertility after spontaneous descent of the testis after the
1358 age of 10]. Ugeskr Laeger. 1985;147(31):2444-7.
1359 234. Raboch J, Pondelickova J. [Andrological findings in adolescents with retractile testis]. Andrologia.
1360 1988;20(5):417-21.
1361 235. Rasmussen TB, Ingerslev HJ, Hostrup H. Natural history of the maldescended testis. Horm Res.
1362 1988;30(4-5):164-6.
1363 236. Caroppo E, Niederberger C, Elhanbly S, Schoor R, Ross L, D'Amato G. Effect of cryptorchidism
1364 and retractile testes on male factor infertility: a multicenter, retrospective, chart review. Fertil Steril.
1365 2005;83(5):1581-4.
1366 237. Caucci M, Barbatelli G, Cinti S. The retractile testis can be a cause of adult infertility. Fertil Steril.
1367 1997;68(6):1051-8.
1368 238. Mieusset R, Bujan LE, Massat G, Mansat A, Pontonnier F. Inconstant ascending testis as a
1369 potential risk factor for spermatogenesis in infertile men with no history of cryptorchism. Hum Reprod.
1370 1997;12(5):974-9.
1371 239. Keys C, Heloury Y. Retractile testes: a review of the current literature. J Pediatr Urol.
1372 2012;8(1):2-6.
1373 240. Goh DW, Hutson JM. Is the retractile testis a normal physiological variant of an anomaly that
1374 requires active treatment? Pediatr Surg Int. 1992;7:249-52.
1375 241. Goh DW, Hutson JM. The retractile testis: time for a reappraisal. J Paediatr Child Health.
1376 1993;29(6):407-8.
1377 242. Boisen KA, Main KM, Rajpert-De Meyts E, Skakkebaek NE. Are male reproductive disorders a
1378 common entity? The testicular dysgenesis syndrome. Ann N Y Acad Sci. 2001;948:90-9.
1379 243. Ferlin A, Bogatcheva NV, Gianesello L, Pepe A, Vinanzi C, Agoulnik AI, et al. Insulin-like factor
1380 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization. Mol Hum
1381 Reprod. 2006;12(6):401-6.
1382 244. Nistal M, Gonzalez-Peramato P, Regadera J, Serrano A, Tarin V, De Miguel MP. Primary
1383 testicular lesions are associated with testicular germ cell tumors of adult men. Am J Surg Pathol.
1384 2006;30(10):1260-8.
1385 245. Virtanen HE, Rajpert-De Meyts E, Main KM, Skakkebaek NE, Toppari J. Testicular dysgenesis
1386 syndrome and the development and occurrence of male reproductive disorders. Toxicol Appl Pharmacol.
1387 2005;207(2 Suppl):501-5.
1388 246. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ, Jr., et al. Male
1389 reproductive health and environmental xenoestrogens. Environ Health Perspect. 1996;104 Suppl 4:741-803.
1390 247. Fisher JS, Macpherson S, Marchetti N, Sharpe RM. Human 'testicular dysgenesis syndrome': a
1391 possible model using in-utero exposure of the rat to dibutyl phthalate. Hum Reprod. 2003;18(7):1383-94.
1392 248. Gabel P, Jensen MS, Andersen HR, Baelum J, Thulstrup AM, Bonde JP, et al. The risk of
1393 cryptorchidism among sons of women working in horticulture in Denmark: a cohort study. Environmental
1394 health : a global access science source. 2011;10:100.
1395 249. Martinez-Arguelles DB, Campioli E, Culty M, Zirkin BR, Papadopoulos V. Fetal origin of
1396 endocrine dysfunction in the adult: the phthalate model. The Journal of steroid biochemistry and molecular
1397 biology. 2013;137:5-17.
1398 250. Sharpe RM. The 'oestrogen hypothesis'- where do we stand now? Int J Androl. 2003;26(1):2-15.
1399 251. Sharpe RM, Skakkebaek NE. Testicular dysgenesis syndrome: mechanistic insights and potential
1400 new downstream effects. Fertil Steril. 2008;89(2 Suppl):e33-8.
1401 252. Bay K, Asklund C, Skakkebaek NE, Andersson AM. Testicular dysgenesis syndrome: possible
1402 role of endocrine disrupters. Best Pract Res Clin Endocrinol Metab. 2006;20(1):77-90.
1403 253. Giwercman A, Rylander L, Hagmar L, Giwercman YL. Ethnic differences in occurrence of TDS--
1404 genetics and/or environment? Int J Androl. 2006;29(1):291-7; discussion 304-6.
1405 254. Nistal M, Regadera J, Winitzky P, Tejerina E, Chemes H. Granular changes in Sertoli cells in
1406 children and pubertal patients. Fertil Steril. 2005;83(5):1489-99.
1407 255. Olwenn VM. Testicular Dysgenesis Syndrome and the Estrogen Hypothesis: A Quantitative
1408 Meta-Analysis. Health Perspect. 2008;116:149-57.
1409 256. Main KM, Skakkebaek NE, Toppari J. Cryptorchidism as part of the testicular dysgenesis
1410 syndrome: the environmental connection. Endocr Dev. 2009;14:167-73.
1411 257. Dalgaard MD, Weinhold N, Edsgard D, Silver JD, Pers TH, Nielsen JE, et al. A genome-wide
1412 association study of men with symptoms of testicular dysgenesis syndrome and its network biology
1413 interpretation. J Med Genet. 2012;49(1):58-65.
1414 258. Hu GX, Lian QQ, Ge RS, Hardy DO, Li XK. Phthalate-induced testicular dysgenesis syndrome:
1415 Leydig cell influence. Trends Endocrinol Metab. 2009;20(3):139-45.
1416 259. Jorgensen N, Rajpert-De Meyts E, Main KM, Skakkebaek NE. Testicular dysgenesis syndrome
1417 comprises some but not all cases of hypospadias and impaired spermatogenesis. Int J Androl.
1418 2010;33(2):298-303.
1419 260. Thorup J, McLachlan R, Cortes D, Nation TR, Balic A, Southwell BR, et al. What is new in
1420 cryptorchidism and hypospadias--a critical review on the testicular dysgenesis hypothesis. J Pediatr Surg.
1421 2010;45(10):2074-86.
1422 261. Toppari J, Virtanen HE, Main KM, Skakkebaek NE. Cryptorchidism and hypospadias as a sign of
1423 testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res A Clin Mol Teratol.
1424 2010;88(10):910-9.